KR102227533B1 - Shampoo compound using oriental medicine and its manufacturing methods - Google Patents
Shampoo compound using oriental medicine and its manufacturing methods Download PDFInfo
- Publication number
- KR102227533B1 KR102227533B1 KR1020190010500A KR20190010500A KR102227533B1 KR 102227533 B1 KR102227533 B1 KR 102227533B1 KR 1020190010500 A KR1020190010500 A KR 1020190010500A KR 20190010500 A KR20190010500 A KR 20190010500A KR 102227533 B1 KR102227533 B1 KR 102227533B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- acid
- hair
- extract
- herbal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002453 shampoo Substances 0.000 title claims abstract description 46
- 238000004519 manufacturing process Methods 0.000 title abstract description 11
- 150000001875 compounds Chemical class 0.000 title description 2
- 229940124595 oriental medicine Drugs 0.000 title 1
- 241000411851 herbal medicine Species 0.000 claims abstract description 49
- 239000000203 mixture Substances 0.000 claims abstract description 45
- 239000000284 extract Substances 0.000 claims abstract description 44
- 235000011511 Diospyros Nutrition 0.000 claims abstract description 19
- 239000007864 aqueous solution Substances 0.000 claims abstract description 19
- 244000236655 Diospyros kaki Species 0.000 claims abstract description 13
- 244000269722 Thea sinensis Species 0.000 claims abstract description 12
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 10
- 244000068988 Glycine max Species 0.000 claims abstract description 10
- 244000234609 Portulaca oleracea Species 0.000 claims abstract description 9
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 9
- 230000001476 alcoholic effect Effects 0.000 claims abstract description 9
- 239000004094 surface-active agent Substances 0.000 claims abstract description 9
- 235000004347 Perilla Nutrition 0.000 claims abstract description 8
- 244000124853 Perilla frutescens Species 0.000 claims abstract description 8
- 244000299790 Rheum rhabarbarum Species 0.000 claims abstract description 8
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims abstract description 8
- 235000009569 green tea Nutrition 0.000 claims abstract description 8
- 235000009108 Urtica dioica Nutrition 0.000 claims abstract description 7
- 239000002280 amphoteric surfactant Substances 0.000 claims abstract description 7
- 239000003963 antioxidant agent Substances 0.000 claims abstract description 7
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 7
- 230000002335 preservative effect Effects 0.000 claims abstract description 6
- 239000003205 fragrance Substances 0.000 claims abstract description 5
- 239000003755 preservative agent Substances 0.000 claims abstract description 5
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 3
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 3
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 3
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 3
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 3
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 3
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 3
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 3
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 3
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 3
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 3
- 244000274883 Urtica dioica Species 0.000 claims abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 77
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 43
- 239000002253 acid Substances 0.000 claims description 22
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 21
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 235000010323 ascorbic acid Nutrition 0.000 claims description 13
- 239000011668 ascorbic acid Substances 0.000 claims description 13
- 229960005070 ascorbic acid Drugs 0.000 claims description 13
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- 125000000217 alkyl group Chemical group 0.000 claims description 10
- 235000013399 edible fruits Nutrition 0.000 claims description 10
- 230000003020 moisturizing effect Effects 0.000 claims description 9
- 235000010374 vitamin B1 Nutrition 0.000 claims description 9
- 239000011691 vitamin B1 Substances 0.000 claims description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 8
- 229930003268 Vitamin C Natural products 0.000 claims description 8
- 235000015097 nutrients Nutrition 0.000 claims description 8
- 235000019154 vitamin C Nutrition 0.000 claims description 8
- 239000011718 vitamin C Substances 0.000 claims description 8
- 235000011054 acetic acid Nutrition 0.000 claims description 7
- 230000002378 acidificating effect Effects 0.000 claims description 7
- 150000001413 amino acids Chemical class 0.000 claims description 7
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 7
- 235000020776 essential amino acid Nutrition 0.000 claims description 7
- 239000003797 essential amino acid Substances 0.000 claims description 7
- 229930195729 fatty acid Natural products 0.000 claims description 7
- 239000000194 fatty acid Substances 0.000 claims description 7
- 150000004665 fatty acids Chemical class 0.000 claims description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 6
- 229930003316 Vitamin D Natural products 0.000 claims description 6
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 6
- 235000006708 antioxidants Nutrition 0.000 claims description 6
- 239000000969 carrier Substances 0.000 claims description 6
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 6
- QBKSWRVVCFFDOT-UHFFFAOYSA-N gossypol Chemical compound CC(C)C1=C(O)C(O)=C(C=O)C2=C(O)C(C=3C(O)=C4C(C=O)=C(O)C(O)=C(C4=CC=3C)C(C)C)=C(C)C=C21 QBKSWRVVCFFDOT-UHFFFAOYSA-N 0.000 claims description 6
- 239000004334 sorbic acid Substances 0.000 claims description 6
- 235000010199 sorbic acid Nutrition 0.000 claims description 6
- 229940075582 sorbic acid Drugs 0.000 claims description 6
- 235000019166 vitamin D Nutrition 0.000 claims description 6
- 239000011710 vitamin D Substances 0.000 claims description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 6
- 229940046008 vitamin d Drugs 0.000 claims description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 229920001184 polypeptide Polymers 0.000 claims description 5
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 5
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 5
- 239000000600 sorbitol Substances 0.000 claims description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 230000008774 maternal effect Effects 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- UIOFUWFRIANQPC-JKIFEVAISA-N Floxacillin Chemical compound N([C@@H]1C(N2[C@H](C(C)(C)S[C@@H]21)C(O)=O)=O)C(=O)C1=C(C)ON=C1C1=C(F)C=CC=C1Cl UIOFUWFRIANQPC-JKIFEVAISA-N 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- LUSZGTFNYDARNI-UHFFFAOYSA-N Sesamol Natural products OC1=CC=C2OCOC2=C1 LUSZGTFNYDARNI-UHFFFAOYSA-N 0.000 claims description 3
- QHOPXUFELLHKAS-UHFFFAOYSA-N Thespesin Natural products CC(C)c1c(O)c(O)c2C(O)Oc3c(c(C)cc1c23)-c1c2OC(O)c3c(O)c(O)c(C(C)C)c(cc1C)c23 QHOPXUFELLHKAS-UHFFFAOYSA-N 0.000 claims description 3
- 229930000755 gossypol Natural products 0.000 claims description 3
- 229950005277 gossypol Drugs 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 2
- 241000018646 Pinus brutia Species 0.000 claims description 2
- 235000011613 Pinus brutia Nutrition 0.000 claims description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 claims 1
- 235000019437 butane-1,3-diol Nutrition 0.000 claims 1
- 210000004209 hair Anatomy 0.000 abstract description 19
- 230000000844 anti-bacterial effect Effects 0.000 abstract description 18
- 241000196324 Embryophyta Species 0.000 abstract description 17
- 230000003779 hair growth Effects 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 15
- 210000004761 scalp Anatomy 0.000 abstract description 14
- 208000017520 skin disease Diseases 0.000 abstract description 14
- 238000000855 fermentation Methods 0.000 abstract description 12
- 230000004151 fermentation Effects 0.000 abstract description 12
- 201000004384 Alopecia Diseases 0.000 abstract description 10
- 230000003676 hair loss Effects 0.000 abstract description 10
- 208000024963 hair loss Diseases 0.000 abstract description 10
- 230000003658 preventing hair loss Effects 0.000 abstract description 10
- 239000003945 anionic surfactant Substances 0.000 abstract description 8
- 208000015181 infectious disease Diseases 0.000 abstract description 7
- 230000001954 sterilising effect Effects 0.000 abstract description 7
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 5
- 235000010663 Lavandula angustifolia Nutrition 0.000 abstract description 4
- 244000241838 Lycium barbarum Species 0.000 abstract description 4
- 239000001102 lavandula vera Substances 0.000 abstract description 4
- 235000018219 lavender Nutrition 0.000 abstract description 4
- 235000010716 Vigna mungo Nutrition 0.000 abstract description 3
- 235000011453 Vigna umbellata Nutrition 0.000 abstract description 3
- 240000001417 Vigna umbellata Species 0.000 abstract description 3
- 230000002458 infectious effect Effects 0.000 abstract description 3
- 244000052769 pathogen Species 0.000 abstract description 3
- 235000012041 food component Nutrition 0.000 abstract description 2
- 244000178870 Lavandula angustifolia Species 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 239000004909 Moisturizer Substances 0.000 abstract 1
- 230000001333 moisturizer Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 description 27
- 230000006870 function Effects 0.000 description 26
- 235000018553 tannin Nutrition 0.000 description 19
- 229920001864 tannin Polymers 0.000 description 19
- 239000001648 tannin Substances 0.000 description 19
- 210000003491 skin Anatomy 0.000 description 17
- 239000000126 substance Substances 0.000 description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 239000004615 ingredient Substances 0.000 description 12
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- -1 isoflavone glycosides Chemical class 0.000 description 10
- 239000003921 oil Substances 0.000 description 10
- 235000019198 oils Nutrition 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 235000000346 sugar Nutrition 0.000 description 9
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 8
- 206010063409 Acarodermatitis Diseases 0.000 description 7
- 201000004624 Dermatitis Diseases 0.000 description 7
- 241000447727 Scabies Species 0.000 description 7
- 230000035876 healing Effects 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 208000005687 scabies Diseases 0.000 description 7
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 6
- 244000025254 Cannabis sativa Species 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 229940024606 amino acid Drugs 0.000 description 6
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 6
- ZZBWSNKBZKPGAK-UHFFFAOYSA-N chrysophanol-9-anthrone Chemical compound C1=CC=C2CC3=CC(C)=CC(O)=C3C(=O)C2=C1O ZZBWSNKBZKPGAK-UHFFFAOYSA-N 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 6
- 229930182470 glycoside Natural products 0.000 description 6
- 231100000614 poison Toxicity 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 5
- 241000219422 Urtica Species 0.000 description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 5
- 229910052802 copper Inorganic materials 0.000 description 5
- 239000010949 copper Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 5
- 230000006806 disease prevention Effects 0.000 description 5
- 150000002338 glycosides Chemical class 0.000 description 5
- 238000010438 heat treatment Methods 0.000 description 5
- 229910052742 iron Inorganic materials 0.000 description 5
- 239000000787 lecithin Substances 0.000 description 5
- 229940067606 lecithin Drugs 0.000 description 5
- 235000010445 lecithin Nutrition 0.000 description 5
- 235000010987 pectin Nutrition 0.000 description 5
- 239000001814 pectin Substances 0.000 description 5
- 229920001277 pectin Polymers 0.000 description 5
- 239000002574 poison Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 4
- 241000723267 Diospyros Species 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 241000238631 Hexapoda Species 0.000 description 4
- 241000270295 Serpentes Species 0.000 description 4
- 240000003829 Sorghum propinquum Species 0.000 description 4
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 4
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 4
- 150000004056 anthraquinones Chemical class 0.000 description 4
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000002131 composite material Substances 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 235000001671 coumarin Nutrition 0.000 description 4
- 235000019197 fats Nutrition 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000000419 plant extract Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 235000017709 saponins Nutrition 0.000 description 4
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 4
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 4
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 229930024421 Adenine Natural products 0.000 description 3
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 244000165082 Lavanda vera Species 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000002193 Pain Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 206010052428 Wound Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229960000643 adenine Drugs 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 3
- 229960003237 betaine Drugs 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 229940074360 caffeic acid Drugs 0.000 description 3
- 235000004883 caffeic acid Nutrition 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 3
- 229960001231 choline Drugs 0.000 description 3
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 3
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 239000000428 dust Substances 0.000 description 3
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 3
- VVEKCQAFOLKNKB-UHFFFAOYSA-N emodine Natural products C1=CC=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O VVEKCQAFOLKNKB-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000000469 ethanolic extract Substances 0.000 description 3
- 229940093915 gynecological organic acid Drugs 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- PXHVJJICTQNCMI-UHFFFAOYSA-N nickel Substances [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- 239000004006 olive oil Substances 0.000 description 3
- 235000008390 olive oil Nutrition 0.000 description 3
- 150000007524 organic acids Chemical class 0.000 description 3
- 235000005985 organic acids Nutrition 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000010865 sewage Substances 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 230000003813 thin hair Effects 0.000 description 3
- 230000001256 tonic effect Effects 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- 235000019168 vitamin K Nutrition 0.000 description 3
- 239000011712 vitamin K Substances 0.000 description 3
- 229940075420 xanthine Drugs 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- XBZYWSMVVKYHQN-MYPRUECHSA-N (4as,6as,6br,8ar,9r,10s,12ar,12br,14bs)-10-hydroxy-2,2,6a,6b,9,12a-hexamethyl-9-[(sulfooxy)methyl]-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid Chemical compound C1C[C@H](O)[C@@](C)(COS(O)(=O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C XBZYWSMVVKYHQN-MYPRUECHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- QUNWUDVFRNGTCO-UHFFFAOYSA-N 1,7-dimethylxanthine Chemical compound N1C(=O)N(C)C(=O)C2=C1N=CN2C QUNWUDVFRNGTCO-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- MFAPGDLENWJYSK-UHFFFAOYSA-N 5-(6,7-dihydroxy-2-oxochromen-5-yl)-6,7-dihydroxychromen-2-one Chemical compound O1C(=O)C=CC2=C1C=C(O)C(O)=C2C1=C(O)C(O)=CC2=C1C=CC(=O)O2 MFAPGDLENWJYSK-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- QKPDYSSHOSPOKH-JNHRPPPUSA-N Chrysophanein Chemical compound C=12C(=O)C3=C(O)C=CC=C3C(=O)C2=CC(C)=CC=1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QKPDYSSHOSPOKH-JNHRPPPUSA-N 0.000 description 2
- QKPDYSSHOSPOKH-UHFFFAOYSA-N Chrysophanein Natural products C=12C(=O)C3=C(O)C=CC=C3C(=O)C2=CC(C)=CC=1OC1OC(CO)C(O)C(O)C1O QKPDYSSHOSPOKH-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- 208000001840 Dandruff Diseases 0.000 description 2
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Natural products C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 2
- 244000055850 Diospyros virginiana Species 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 2
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 2
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 2
- 208000006877 Insect Bites and Stings Diseases 0.000 description 2
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 2
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- 244000108452 Litchi chinensis Species 0.000 description 2
- 241000588653 Neisseria Species 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 235000015742 Nephelium litchi Nutrition 0.000 description 2
- 206010029148 Nephrolithiasis Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 235000002597 Solanum melongena Nutrition 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 206010041349 Somnolence Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 229930003451 Vitamin B1 Natural products 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 239000004568 cement Substances 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 229960000956 coumarin Drugs 0.000 description 2
- 150000004775 coumarins Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 235000011869 dried fruits Nutrition 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- QLHFZUMWECUDIA-UHFFFAOYSA-N emidine Natural products CC(O)C1CCC2(O)C3CC=C4CC(CCC4(C)C3CCC12C)OC5CC(O)C(OC6CC(O)C(OC7CC(O)C(O)C(C)O7)C(C)O6)C(C)O5 QLHFZUMWECUDIA-UHFFFAOYSA-N 0.000 description 2
- 239000003344 environmental pollutant Substances 0.000 description 2
- 208000028104 epidemic louse-borne typhus Diseases 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 229930182830 galactose Natural products 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- NQYPTLKGQJDGTI-FCVRJVSHSA-N hyperoside Natural products OC[C@H]1O[C@@H](OC2=C(Oc3cc(O)cc(O)c3[C@H]2O)c4ccc(O)c(O)c4)[C@H](O)[C@@H](O)[C@H]1O NQYPTLKGQJDGTI-FCVRJVSHSA-N 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000011630 iodine Substances 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 210000003097 mucus Anatomy 0.000 description 2
- 201000008383 nephritis Diseases 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 229910017464 nitrogen compound Inorganic materials 0.000 description 2
- 150000002830 nitrogen compounds Chemical class 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000003973 paint Substances 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 231100000719 pollutant Toxicity 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Natural products COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- 229960000278 theophylline Drugs 0.000 description 2
- 229960003495 thiamine Drugs 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 2
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 2
- 206010061393 typhus Diseases 0.000 description 2
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 2
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- XMGQYMWWDOXHJM-SNVBAGLBSA-N (-)-α-limonene Chemical compound CC(=C)[C@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-SNVBAGLBSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-JLGXGRJMSA-N (3R,3'R)-beta,beta-carotene-3,3'-diol Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-JLGXGRJMSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- RUMOYJJNUMEFDD-SNVBAGLBSA-N (R)-(+)-Perillaldehyde Natural products CC(=C)[C@H]1CCC(C=O)=CC1 RUMOYJJNUMEFDD-SNVBAGLBSA-N 0.000 description 1
- 229930182836 (R)-noradrenaline Natural products 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- UFLHIIWVXFIJGU-ARJAWSKDSA-N (Z)-hex-3-en-1-ol Chemical compound CC\C=C/CCO UFLHIIWVXFIJGU-ARJAWSKDSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- HBOQXIRUPVQLKX-UHFFFAOYSA-N 2,3-di(octadeca-9,12-dienoyloxy)propyl octadeca-9,12-dienoate Chemical compound CCCCCC=CCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCC=CCCCCC)COC(=O)CCCCCCCC=CCC=CCCCCC HBOQXIRUPVQLKX-UHFFFAOYSA-N 0.000 description 1
- LVRFTAZAXQPQHI-UHFFFAOYSA-N 2-hydroxy-4-methylvaleric acid Chemical compound CC(C)CC(O)C(O)=O LVRFTAZAXQPQHI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- HCXVJBMSMIARIN-ZETWWWAOSA-N 24alpha-Ethyl-koprostanol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C HCXVJBMSMIARIN-ZETWWWAOSA-N 0.000 description 1
- YGHRJJRRZDOVPD-UHFFFAOYSA-N 3-methylbutanal Chemical compound CC(C)CC=O YGHRJJRRZDOVPD-UHFFFAOYSA-N 0.000 description 1
- ATEFPOUAMCWAQS-UHFFFAOYSA-N 7,8-dihydroxycoumarin Chemical compound C1=CC(=O)OC2=C(O)C(O)=CC=C21 ATEFPOUAMCWAQS-UHFFFAOYSA-N 0.000 description 1
- PFWLFWPASULGAN-UHFFFAOYSA-N 7-methylxanthine Chemical compound N1C(=O)NC(=O)C2=C1N=CN2C PFWLFWPASULGAN-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 241000670727 Amida Species 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 206010003645 Atopy Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- 208000000412 Avitaminosis Diseases 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000030523 Catechol oxidase Human genes 0.000 description 1
- 108010031396 Catechol oxidase Proteins 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 235000005940 Centaurea cyanus Nutrition 0.000 description 1
- 240000004385 Centaurea cyanus Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 241000037488 Coccoloba pubescens Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 229920000296 Glucogallin Polymers 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021135 Hypovitaminosis Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- AMIMRNSIRUDHCM-UHFFFAOYSA-N Isopropylaldehyde Chemical compound CC(C)C=O AMIMRNSIRUDHCM-UHFFFAOYSA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 235000015940 Leptospermum coriaceum Nutrition 0.000 description 1
- 244000021209 Leptospermum coriaceum Species 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 206010028836 Neck pain Diseases 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000008896 Opium Substances 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 244000294611 Punica granatum Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 235000016976 Quercus macrolepis Nutrition 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- PEFASEPMJYRQBW-HKWQTAEVSA-N Robinin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 PEFASEPMJYRQBW-HKWQTAEVSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000008422 Schisandra chinensis Nutrition 0.000 description 1
- 240000006079 Schisandra chinensis Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229930187719 Soyasaponin Natural products 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000005448 Trichomonas Infections Diseases 0.000 description 1
- 206010044620 Trichomoniasis Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 208000036029 Uterine contractions during pregnancy Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 239000004213 Violaxanthin Substances 0.000 description 1
- SZCBXWMUOPQSOX-LOFNIBRQSA-N Violaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C12OC1(C)CC(O)CC2(C)C)C=CC=C(/C)C=CC34OC3(C)CC(O)CC4(C)C SZCBXWMUOPQSOX-LOFNIBRQSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- JKQXZKUSFCKOGQ-LQFQNGICSA-N Z-zeaxanthin Natural products C([C@H](O)CC=1C)C(C)(C)C=1C=CC(C)=CC=CC(C)=CC=CC=C(C)C=CC=C(C)C=CC1=C(C)C[C@@H](O)CC1(C)C JKQXZKUSFCKOGQ-LQFQNGICSA-N 0.000 description 1
- QOPRSMDTRDMBNK-RNUUUQFGSA-N Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCC(O)C1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C QOPRSMDTRDMBNK-RNUUUQFGSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000003504 ach effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 150000004996 alkyl benzenes Chemical class 0.000 description 1
- 125000006177 alkyl benzyl group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- JKQXZKUSFCKOGQ-LOFNIBRQSA-N all-trans-Zeaxanthin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2=C(C)CC(O)CC2(C)C JKQXZKUSFCKOGQ-LOFNIBRQSA-N 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- JZVFJDZBLUFKCA-FXIAWGAOSA-N alpha-Spinasterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-FXIAWGAOSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229930182482 anthraquinone glycoside Natural products 0.000 description 1
- 150000008139 anthraquinone glycosides Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003656 anti-hair-loss Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- GDVRUDXLQBVIKP-UHFFFAOYSA-N beta-D-glucogallin Natural products OC1C(O)C(O)C(CO)OC1OC(=O)C1=CC(O)=C(O)C(O)=C1 GDVRUDXLQBVIKP-UHFFFAOYSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 235000020279 black tea Nutrition 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000004820 blood count Methods 0.000 description 1
- 229940119577 blood stop Drugs 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 239000004566 building material Substances 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 229940097217 cardiac glycoside Drugs 0.000 description 1
- 239000002368 cardiac glycoside Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- BBRAOTYOIAGHRI-UHFFFAOYSA-N citreorosein Natural products C1=C(CO)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O BBRAOTYOIAGHRI-UHFFFAOYSA-N 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000002817 coal dust Substances 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- YBGKGTOOPNQOKH-UHFFFAOYSA-N daphnetin Natural products OC1=CC=CC2=C1OC(=O)C=C2O YBGKGTOOPNQOKH-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000007242 delphinidin Nutrition 0.000 description 1
- FFNDMZIBVDSQFI-UHFFFAOYSA-N delphinidin chloride Chemical compound [Cl-].[O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 FFNDMZIBVDSQFI-UHFFFAOYSA-N 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930182486 flavonoid glycoside Natural products 0.000 description 1
- 150000007955 flavonoid glycosides Chemical class 0.000 description 1
- 229940124600 folk medicine Drugs 0.000 description 1
- 229940013688 formic acid Drugs 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229940039229 general nutrients Drugs 0.000 description 1
- XTLWNMXYCHABQH-UHFFFAOYSA-N germanicol Natural products CC1(C)CCC2(C)CCC3(C)C(CCC4(C)C5(C)CCC(O)C(C)(C)C5CCC34C)C2=C1 XTLWNMXYCHABQH-UHFFFAOYSA-N 0.000 description 1
- 208000007565 gingivitis Diseases 0.000 description 1
- KGHSLXLLBHRMML-VKISENBKSA-N glucogallin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](OC)O[C@H]1OC(=O)C1=CC(O)=C(O)C(O)=C1 KGHSLXLLBHRMML-VKISENBKSA-N 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 230000003803 hair density Effects 0.000 description 1
- 230000003646 hair health Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 150000002505 iron Chemical class 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- DDELFAUOHDSZJL-UHFFFAOYSA-N kaempferol 3-O-rutinoside-7-O-rhamnoside Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C1=O DDELFAUOHDSZJL-UHFFFAOYSA-N 0.000 description 1
- PEFASEPMJYRQBW-UHFFFAOYSA-N kaempferol 7-O-alpha-L-rhamnopyradoside 3-O-beta-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(OC4C(C(O)C(O)C(C)O4)O)C=C3OC=2C=2C=CC(O)=CC=2)=O)O1 PEFASEPMJYRQBW-UHFFFAOYSA-N 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 241000238565 lobster Species 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- DYUUPIKEWLHQGQ-FJOIUHRLSA-N lutein 5,6-epoxide Chemical compound C(/[C@]12[C@@](O1)(C)C[C@@H](O)CC2(C)C)=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C DYUUPIKEWLHQGQ-FJOIUHRLSA-N 0.000 description 1
- IQPNAANSBPBGFQ-UHFFFAOYSA-N luteolin Chemical compound C=1C(O)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C(O)=C1 IQPNAANSBPBGFQ-UHFFFAOYSA-N 0.000 description 1
- LRDGATPGVJTWLJ-UHFFFAOYSA-N luteolin Natural products OC1=CC(O)=CC(C=2OC3=CC(O)=CC(O)=C3C(=O)C=2)=C1 LRDGATPGVJTWLJ-UHFFFAOYSA-N 0.000 description 1
- 235000009498 luteolin Nutrition 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000009245 menopause Effects 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- DNABNTQMDXKPON-UHFFFAOYSA-N neposide Natural products CC(=O)C1=C(C)C=C2C=CC=C(O)C2=C1OC1OC(CO)C(O)C(O)C1O DNABNTQMDXKPON-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229960001027 opium Drugs 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- RUMOYJJNUMEFDD-UHFFFAOYSA-N perillyl aldehyde Chemical compound CC(=C)C1CCC(C=O)=CC1 RUMOYJJNUMEFDD-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 230000003716 rejuvenation Effects 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 230000002940 repellent Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- PEFASEPMJYRQBW-XMWKPCQISA-N robinin Natural products O(C[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@H](OC2=C(c3ccc(O)cc3)Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@@H](O)[C@@H](C)O4)c3)C2=O)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 PEFASEPMJYRQBW-XMWKPCQISA-N 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 229940124513 senna glycoside Drugs 0.000 description 1
- 229930186851 sennoside Natural products 0.000 description 1
- IPQVTOJGNYVQEO-KGFNBKMBSA-N sennoside A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=CC2=C1C(=O)C1=C(O)C=C(C(O)=O)C=C1[C@@H]2[C@H]1C2=CC(C(O)=O)=CC(O)=C2C(=O)C2=C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)C=CC=C21 IPQVTOJGNYVQEO-KGFNBKMBSA-N 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000011973 solid acid Substances 0.000 description 1
- 229930193551 sterin Natural products 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- GGGUGZHBAOMSFJ-GADYQYKKSA-N taraxerol Chemical compound CC([C@@H]1CC2)(C)[C@@H](O)CC[C@]1(C)[C@@H]1[C@]2(C)C2=CC[C@@]3(C)CCC(C)(C)C[C@H]3[C@]2(C)CC1 GGGUGZHBAOMSFJ-GADYQYKKSA-N 0.000 description 1
- HYTFUKZLSYXRDX-UHFFFAOYSA-N taraxerol Natural products CC1CCCC2C3(C)CCC4(C)C5CC(C)(C)CCC5(C)C=CC4(C)C3C(O)CC12C HYTFUKZLSYXRDX-UHFFFAOYSA-N 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- DPUOLQHDNGRHBS-MDZDMXLPSA-N trans-Brassidic acid Chemical compound CCCCCCCC\C=C\CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-MDZDMXLPSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- SZCBXWMUOPQSOX-PSXNNQPNSA-N violaxanthin Chemical compound C(\[C@@]12[C@](O1)(C)C[C@H](O)CC2(C)C)=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/[C@]1(C(C[C@@H](O)C2)(C)C)[C@]2(C)O1 SZCBXWMUOPQSOX-PSXNNQPNSA-N 0.000 description 1
- 235000019245 violaxanthin Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 208000030401 vitamin deficiency disease Diseases 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002351 wastewater Substances 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
- 235000008210 xanthophylls Nutrition 0.000 description 1
- 235000010930 zeaxanthin Nutrition 0.000 description 1
- 239000001775 zeaxanthin Substances 0.000 description 1
- 229940043269 zeaxanthin Drugs 0.000 description 1
- 229940043810 zinc pyrithione Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/596—Mixtures of surface active compounds
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
음이온 계면 활성제 또는 양성이온 계면활성제 중에서 선택되는 하나의 계면활성제 30중량%의 수용액 56~67중량%; 제1군의 한방식물약재 조성물(쌀 및 콩배아 25중량%, 떫은감 25%, 송구지, 마디풀, 산모, 화건초 및 솟수 각각 10중량%)의 추출액 12~16중량%; 제2군의 한방식물약재 조성물(어성초 50중량%, 쇠비름 25중량%, 대황 25중량%)의 추출액 9~12중량%; 제3군의 한방식물약재 조성물(자소엽, 녹차잎, 당광나무, 어성초,하수오, 구기자, 쐐기풀의 각각 동일량)의 알콜발효추출액 6~8중량%; 피부와 두피 및 모발의 영양성분 3~4중량%; 보습제 1.5~2중량%; 천연항산화제 0.8~1중량%; 보존제 0.4~0.6중량%; 라벤드향 0.3~0.5중량%;으로 조성된 한방식물약재를 이용한 샴푸조성물과 그 제조방법에 관한 것이다.
솜털과 아주 가는 머리카락이 남아있는 대머리형은 솜털과 아주 가는 머리카락이 굵어지면서 자라나 두피를 은폐하고 있으나 머리카락이 아주 가늘고 자라는 길이가 3~4cm를 자라면 더 자라지 않고 밀도가 희박한 편이다, 그박에 대머리의 남자 2며은 육모의 효과가 나타나지 않고 탈모방지효과는 있는 것으로 확인하였다. 나머지 지인들도 거의 동일한 결과를 확인하므로서 본 발명 샴푸로부터 발모(육모)효과와 탈모방지효과가 있는 것으로 확인되었다.
상술한 바와 같이 본 발명 샴푸조성물은 지속적으로 사용할 경우 각종 피부질환의 예방 및 치유효과가 있고 항균 및 살균효과가 있어 전염성의 병원균에 의한 감염을 에방할 수 있어 위생적이라 할 수 있고 탈모방지 및 발모효과를 기대할 수 있는 다기능성의 한방약재식물을 이용한 샴푸조성물과 그 제조방법이라 할 수 있다.56 to 67% by weight of an aqueous solution of 30% by weight of one surfactant selected from anionic surfactants or amphoteric surfactants; 12 to 16% by weight of the extract of the herbal composition of the first group (25% by weight of rice and soybean germ, 25% astringent persimmon, 10% by weight, respectively); 9 to 12% by weight of the extract of the herbal composition of the second group (50% by weight of Eoseongcho, 25% by weight of purslane, 25% by weight of rhubarb); 6-8% by weight of alcoholic fermentation extract of the third group's herbal composition (perilla leaf, green tea leaf, danggwang tree, Eoseongcho, hawthorn, wolfberry, and nettle in the same amount); 3-4% by weight of nutritional components of skin, scalp and hair; 1.5-2% by weight of a moisturizer; 0.8 to 1% by weight of a natural antioxidant; 0.4 to 0.6% by weight of a preservative; It relates to a shampoo composition and a method of manufacturing the same, using an herbal medicine composed of 0.3 to 0.5% by weight of lavender fragrance.
The bald type, with downy and very fine hair, grows thicker and hides the scalp, but if the hair is very thin and grows 3~4cm in length, it does not grow further and the density is thin. It was confirmed that the 2nd generation of males did not show the effect of hair growth and had the effect of preventing hair loss. As the rest of the acquaintances confirmed almost the same results, it was confirmed that the shampoo of the present invention has a hair growth (hair growth) effect and a hair loss prevention effect.
As described above, when the shampoo composition of the present invention is used continuously, it can prevent and cure various skin diseases, and has antibacterial and sterilizing effects, so it can prevent infection by infectious pathogens, so it can be said to be hygienic, and prevent hair loss and hair growth. It can be said that it is a shampoo composition and its manufacturing method using multifunctional herbal medicinal plants that can be expected.
Description
본 발명은 한방 식물약재를 주성분으로 하는 샴푸조성물 및 그 제조방법에 관한 것으로서, 구체적으로는 아미노산 또는 폴리펩타이드에 지방산을 반응시켜서 된 약산성의 음이온 계면활성제 또는 베타인, 알킬암포디아세테이트, 알킬암포디푸로피오네이트, 아미다졸린의 양성이온 계면활성제 중에서 선택되는 하나 이상의 계면활성제 30중량%의 수용액 56~67중량%; 피부질환 예방 및 치유기능을 갖는 쌀 및 콩의 배아 25중량%, 초록색의 미성숙 떪은 감 25중량%, 송구지, 마디풀, 산모, 화전초 및 속수 각각 10중량%로 이루어진 제1군의 한방 식물약재 추출액 12~16중량%; 항균성 및 살균성을 갖는 어성초 50중량%, 쇠비름 25중량%, 및 대황(장군풀) 25%로 이루어진 제2군의 한방식물약재의 에탄올 수용액 추출액 9~12중량%; 발모기능 및 탈모방지기능을 갖는 자소엽, 녹차잎, 당광나무, 어성초, 하수오 및 창포, 쐐기풀을 각각 동량으로 이루어진 제3군의 한방 식물약재의 알콜발효추출액 6~8중량%; 샴푸조성물 분야에서 알려진 담체들로서 피부 두피 및 모발의 영양성분으로 아스코트브산, 필수아미노산, 비타민 B1,B2,B6, 비타민C, 비타민D, 아세트산 중에서 선택되는 하나 이상의 영양성분 3~4중량%; 프로피렌글리콜, 1:3부틸렌글리콜, 솔비톨, 히알루산나트륨 중에서 선택되는 하나 이상의 보습제 1.5~2중량%; 변질방지제로서 고시폴(gossypol), 시사몰(sesamol), 시트르산(citric acid) 및 아스코르브산을 각각 동량으로 이루어진 천연 항산화제 0.8~1중량%; 소르브산 0.4~0.6중량%; 라벤드향 0.3~0.5중량%;로 조성된 한방식물약재를 주성분으로 하는 샴푸조성물 및 그 제조방법에 관한 것이다. The present invention relates to a shampoo composition and a method for producing the same, and specifically, a shampoo composition containing herbal herbal medicines as a main component, and specifically, a weakly acidic anionic surfactant or betaine, alkyl amphodiacetate, alkyl ampodiate obtained by reacting a fatty acid with an amino acid or a polypeptide. 56 to 67% by weight of an aqueous solution of 30% by weight of one or more surfactants selected from the amphoteric surfactants of furopionate and amidazoline; Herbal plant medicinal materials of the 1st group consisting of 25% by weight of rice and soybean germ, 25% by weight of green immature sweet persimmon, and 10% by weight each of sorghum, cornflower, maternal, hwajeoncho, and soybean, which have skin disease prevention and healing functions 12 to 16% by weight of the extract; Eoseongcho 50% by weight having antibacterial and bactericidal properties, purslane 25% by weight, and 9 to 12% by weight of the ethanol aqueous solution extract of the herbal medicine of the second group consisting of 25% of rhubarb (janggun grass); 6-8% by weight of alcoholic fermented extract of herbal plant medicines of the 3rd group, each consisting of equal amounts of perilla leaf, green tea leaf, danggwang tree, Eoseongcho, sorghum and iris, and nettle, each having a hair growth function and a hair loss prevention function; As carriers known in the field of shampoo compositions, 3-4% by weight of one or more nutrients selected from ascotbic acid, essential amino acids, vitamins B1, B2, B6, vitamin C, vitamin D, and acetic acid as nutritional components of the skin scalp and hair; 1.5 to 2% by weight of one or more moisturizing agents selected from propylene glycol, 1:3 butylene glycol, sorbitol, and sodium hyalurate; 0.8 to 1% by weight of a natural antioxidant consisting of the same amount, respectively, of gossypol, sesamol, citric acid and ascorbic acid as an anti-deterioration agent; 0.4 to 0.6% by weight of sorbic acid; It relates to a shampoo composition and a method for producing the same, comprising as a main component an herbal medicine composed of a lavender fragrance of 0.3 to 0.5% by weight.
최근 우리 주변에서 발생하고 있는 극심한 공해물질로서 중국으로부터 유입되는 황사와 함께 석탄분진 및 유해성분진 그리고 생활공간인 시멘트 구조물에 의한 시멘트 증후군, 실내공간의 건축자재로 사용된 접착제, 페인트 등에서 발생하는 증발성 유기화합물인 포름알데히드 등의 공해물질에 노출되므로서 눈병, 건선피부, 아토피성 피부질환이 빈번히 발생하므로서 피부관리와 관련성이 깊은 샴푸의 질적 향상과 친환경성이 절실히 요구되고 있다.Recently, as an extremely pollutant occurring around us, coal dust and harmful constituents along with yellow dust from China, cement syndrome caused by cement structures as living spaces, evaporation from adhesives and paints used as building materials in indoor spaces. Due to exposure to pollutants such as formaldehyde, which is an organic compound, eye diseases, psoriasis skin, and atopic skin diseases frequently occur, the quality improvement and eco-friendliness of shampoos, which are deeply related to skin care, are urgently required.
종래 널리 사용되어온 음이온 계면활성제로 알킬 벤질 슬폰산은 탈지력이 강한 하드타입으로서 피부에 장애가 있어 현재의 샴푸제에는 사용되지 않고 있으며 동일한 석유계라도 소프트타입의 알킬 에스텔 슬폰산은 품질도 좋고 가격도 저렴해서 널리 사용되고 있으며 환경차원에서 하드타입은 사용후 폐수가 되어 하수에 유입되는 경우 미생물에 분해되지 않고 지하수에 흘러들거나 오수처리장에서 거품을 일게하거나 해수로 유입되어 어류에 영향을 주는 이른바 자연환경파괴의 공해를 일으키게 되고 미생물에 분해되어 활성제로서의 작용이 없어져 공해를 일으키지 않는 소프트 타입의 계면활성제가 있다.Alkyl benzyl sulfonic acid as an anionic surfactant that has been widely used in the past is a hard type with strong degreasing power and is not used in current shampoos due to skin disorders. Alkyl ester sulfonic acid of the same petroleum type is of good quality and inexpensive. In terms of environment, the hard type is a so-called pollution of the natural environment that affects fish by flowing into the groundwater without being decomposed by microorganisms when flowing into the sewage as wastewater after use, creating bubbles in the sewage treatment plant, or entering seawater. There are soft-type surfactants that do not cause pollution because they are decomposed by microorganisms and do not act as active agents.
상기 알킬벤젠슬폰산을 대신하여 등장한 고급알콜계의 세정제는 소프트타입으로서 주로 라우릴 알콜에 황산을 반응시켜 수산화나트륨 또는 트리에탄올아민으로 중화하여 만든것으로 이 계통의 것은 기포력도 적당하고 세정력도 온화하지만 눈의 각막과 피부에 다소의 자극이 있어 현재 다른 샴푸들로 이행해가고 있는 실정이다.The higher-grade alcohol-based detergent that appeared in place of the above alkylbenzene sulfonic acid is a soft type, mainly made by reacting sulfuric acid with lauryl alcohol and neutralizing it with sodium hydroxide or triethanolamine. There is some irritation to the cornea and skin of the eye, so it is currently moving to other shampoos.
또한 비듬, 가려움증을 치료 및 예방하기 위해서 사용되는 아연 피리티온은 수불온성이고 비중이 커서 균일한 분산상태를 유지하는 것이 어렵고 눈에 대한 자극성이 매우 심하다는 문제점이 있다.In addition, zinc pyrithione, which is used to treat and prevent dandruff and itching, has a problem in that it is water-inothermic and has a large specific gravity, so it is difficult to maintain a uniform dispersion state, and irritation to the eyes is very severe.
그 밖에 모발의 보호목적 보다는 세정력 위주로 화학적 합성물질을 사용한 샴푸를 자주 사용할 경우 지나친 탈지로 인해 모발과 두피가 손상될 수 있고 염색, 탈색, 퍼머넌트, 웨이브, 드라이처리 등이 잦을 경우 이 또한 모발이 가늘어지고 약해질 수 있으며 이로 인해 비듬을 동반한 탈모로 이어지게 된다.In addition, if you frequently use shampoos that use chemical synthetic substances for cleaning power rather than for the purpose of protecting the hair, excessive degreasing can damage the hair and scalp.If dyeing, bleaching, permanent, wave, dry treatment, etc. are frequent, the hair will also be thin. They may lose weight and become weak, which can lead to hair loss accompanied by dandruff.
탈모현상은 상기 요인 이외에도 과다한 합성 항생물질의 복용, 비타민 및 미량성분 부족, 불안, 스트레스에 의한 요인들도 있지만 전술한 바와 같이 공해발생으로 자연환경을 오염시키고, 인체에 유해하며, 피부 및 두피 및 모발에 손상을 줄 수 있는 주된 요인이 샴푸 조성물에 있다고 할 수 있으며 샴푸조성물로는 유해한 화학적 합성물질을 사용함에 있다고 볼 수 있다.In addition to the above factors, hair loss is caused by excessive use of synthetic antibiotics, lack of vitamins and trace components, anxiety, and stress. It can be said that the main factor that can damage the hair is in the shampoo composition, and it can be seen that the use of harmful chemical synthetic substances as the shampoo composition.
상기와 같은 이유로 최근에는 샴푸조성물에 가브적 화학적 합성물질을 줄이고 샴푸조성물을 한방식물과 같은 천연물로 대체 이행하는 추세라 할 수 있으며 그 종래기술을 알아보면, 대한민국 등록특허 제10-382602호(등록일자: 2003.4.18., 발명의 명칭: 탈모방지 및 모발생장 촉진 조성물)는 식물 영양학적인 재료로서 클로렐라(Chlorella) 68∼19 중량%, 효모 41∼13 중량%, 백강잠 33∼13 중량% 및 화분 46∼19 중량%, 가지 18∼6 중량%, 죽염 002∼032 중량% 또는 우골분 002∼23 중량%를 함유하고, 생약으로서 천마 18∼22 중량%, 산약 18∼14 중량%, 호유자 24∼46 중량%, 백자인 24∼32 중량%, 저실자 24∼32 중량%, 황정 27∼14 중량%, 유근피 2.7∼6 중량%, 상백피 27∼31 중량%, 연전초 27∼31 중량%, 신이화 27∼31 중량%, 지부자 54∼60 중량%, 차전자 27∼31 중량%, 퇴사자 18∼22 중량%, 동규자 41∼45 중량%, 목통 41∼45 중량%, 오미자 28∼32 중량%, 음양곽 41∼45 중량%, 파극 18∼22 중량%, 황기 27∼31 중량%, 후박 27∼31 중량% 또는 건강 27∼31중량%를 포함하며, 전해질로서 해조회분 08∼22 중량%, 황산아연 002∼12 중량% 및 산화마그네슘 002∼07 중량%를 함유하여 우수한 탈모 예방효과 및 발모 촉진효과를 나타내는 조성물이 제안되어 있다.For the above reasons, in recent years, it can be said that there is a trend of reducing chemical synthetic substances in shampoo compositions and replacing shampoo compositions with natural products such as herbal medicines. Date: 2003.4.18., Title of the invention: Composition for preventing hair loss and promoting hair growth) is a plant nutritional material, which is 68-19% by weight of Chlorella, 41-13% by weight of yeast, 33-13% by weight of white chinensis, and pollen It contains 46 to 19% by weight, 18 to 6% by weight of eggplant, 002 to 032% by weight of bamboo salt, or 002 to 23% by weight of beef bone meal, and 18 to 22% by weight of Chunma, 18 to 14% by weight of Sanyak, Hoyuja 24 ∼46% by weight, 24 to 32% by weight of white porcelain, 24 to 32% by weight of low fruit, 27 to 14% by weight of Hwangjeong, 2.7 to 6% by weight of Yugeunpi, 27 to 31% by weight of Sangbaek, 27 to 31% by weight of Yeonjeoncho, Shin Ewha 27 to 31% by weight, 54 to 60% by weight of branch, 27 to 31% by weight of Chajeon, 18 to 22% by weight of retired persons, 41 to 45% by weight of Donggyuja, 41 to 45% by weight of neck pain, 28 to 32% by weight of Schisandra chinensis, Eumyanggwak 41-45% by weight, seaweed 18-22% by weight, Astragalus 27-31% by weight, Hubak 27-31% by weight or healthy 27-31% by weight, seaweed ash 08-22% by weight as electrolyte, zinc sulfate A composition containing 002-12% by weight and 002-07% by weight of magnesium oxide showing excellent hair loss prevention effect and hair growth promoting effect has been proposed.
이러한 종래기술은 신장 및 순환기 기능의 저하를 보강시켜 성별에 상관없이 우수한 탈모에방효과 및 탈모 촉진효과를 나타낼 뿐만 아니라 모발의 굵기를 증가시키는 효과를 나타내며 생체내에서 독성이 나타나지 않아 탈모 방지제 및 모발생장 촉진제로 유용하게 이용될 수 있다고 주장하고 있으나, 탈모 에방이나 발모 촉진에 검증되지 못한 한약재를 사용하고 있어 실제 발모 촉진 효과를 확인할 수 없는 문제점이 있다.This prior art reinforces the deterioration of kidney and circulatory function, not only shows excellent anti-hair loss effect and hair loss promotion effect regardless of gender, but also increases the thickness of hair, and does not show toxicity in vivo, so it is a hair loss inhibitor and hair loss agent. It is claimed that it can be useful as a growth accelerator, but there is a problem in that the actual hair growth promoting effect cannot be confirmed because an unproven herbal medicine is used for preventing hair loss or promoting hair growth.
또한 대한민국 등록특허 제10-1050613호에는 항산화 효과와 항주름 및 보습효과를 가지는 식물 추출물을 함유하는 화장료 조성물이 개시되어 있다.In addition, Korean Patent Registration No. 10-1050613 discloses a cosmetic composition containing a plant extract having antioxidant effects, anti-wrinkle and moisturizing effects.
상기 화장료 조성물은 대나무, 잣나무, 참나무, 자작나무, 감귤나무, 녹나무로 구성된 식물로부터 풍부하고 유용한 식물 추출물의 유용성분들이 시간이 지남에 따라 방출량이 급격히 낮아져 시간경과에 따라 식물 추출물의 효과가 크게 저하되는 문제점이 있다.The cosmetic composition is rich in useful ingredients of plant extracts from plants consisting of bamboo, pine, oak, birch, citrus, and camphor trees, and the amount of release of the useful ingredients of the plant extract rapidly decreases over time, and the effect of the plant extract greatly decreases over time. There is a problem.
본 발명은 상기와 같은 문제점을 해결하기 위한 것으로서, 공해를 발생시키지 않는 친환경성이고, 인체에 해가 없으며, 피부, 두피 및 모발에 자극을 줄이기 위해 샴푸조성물에 가급적 화학 합성물질을 줄이고 천연의 한방식물약재로 대체하므로서 피부질환예방 및 치유기능, 항균 및 살균기능, 발모 및 탈모 방지기능이 부여된 한방식물약재를 이용한 샴푸조성물 및 그 제조방법을 제공함에 그 목적이 있다.The present invention is intended to solve the above problems, is eco-friendly that does not cause pollution, is harmless to the human body, and in order to reduce irritation to the skin, scalp and hair, reduce chemical synthetic substances in the shampoo composition as much as possible and natural herbal medicine The purpose of this is to provide a shampoo composition and a method of manufacturing the same, using herbal medicines that are provided with skin disease prevention and healing functions, antibacterial and sterilizing functions, and hair growth and hair loss prevention functions by replacing them with plant medicinal materials.
본 발명이 해결하고자 하는 과제는 이상에 언급한 과제들에 제한되지 않으며, 언급되지 않는 또 다른 과제들은 아래의 기재로부터 당업자에게 명확하게 이해될 수 있을 것이다.The problem to be solved by the present invention is not limited to the problems mentioned above, and other problems that are not mentioned will be clearly understood by those skilled in the art from the following description.
이와 같은 목적을 달성하기 위하여, 본 발명은 아미노산 또는 폴리펩타이드에 지방산을 반응시켜서 된 PH 4.5~5.5 범위인 약산성의 음이온 계면활성제 또는 베타인, 알킬암포디아세테이트, 알킬암포디푸로피오네이트, 아미다졸린의 양성이온 계면활성제 중에서 선택되는 하나 이상의 계면활성제 30중량%의 수용액 56~67중량%; 피부질환 예방 및 치유기능을 갖는 제1군의 한방 식물약재의 혼합추출액 12~16중량%; 항균성 및 살균성을 갖는 제2군 한방식물약재의 에탄올 추출액 9~12중량%; 발모기능 및 탈모방지기능을 갖는 제3군의 한방 식물약재의 알콜발효추출액 6~8중량%; 이하 샴푸 조성물 분야에서 널리 알려진 샴푸조성물 재재의 담체들로서 피부 두피 및 모발의 영양성분으로 아스코트브산, 필수아미노산, 비타민 B1,B2,B6, 비타민C, 비타민D, 아세트산 중에서 선택되는 하나 이상의 영양성분 3~4중량%; 보습제로서 프로피렌글리콜, 1:3부틸렌글리콜, 솔비톨, 히알루산나트륨 중에서 선택되는 하나 이상의 보습제 1.5~2중량%; 변질방지제로서 천연 항산화제 0.8~1중량%; 보존제(소르브산) 0.4~0.6중량%; 라벤드향 0.3~0.5중량%;로 조성된 한방식물약재를 주성분으로 하는 샴푸조성물과 그 제조방법으로서, In order to achieve this object, the present invention is a weakly acidic anionic surfactant or betaine, alkyl amphodiacetate, alkyl ampodifuropionate, amida, which is a pH in the range of 4.5 to 5.5, obtained by reacting a fatty acid with an amino acid or a polypeptide. 56 to 67% by weight of an aqueous solution of 30% by weight of one or more surfactants selected from the amphoteric surfactants of sleepy; 12-16% by weight of a mixed extract of herbal herbal medicines of the first group having skin disease prevention and healing functions; 9 to 12% by weight of ethanol extract of the second group herbal medicines having antibacterial and bactericidal properties; 6-8% by weight of alcoholic fermentation extract of herbal plant medicines of group 3 having hair growth function and hair loss prevention function; One or more nutritional ingredients selected from ascotbic acid, essential amino acids, vitamins B1, B2, B6, vitamin C, vitamin D, and acetic acid as nutrients for skin scalp and hair as carriers for shampoo composition materials widely known in the shampoo composition field below. -4% by weight; 1.5 to 2% by weight of at least one moisturizing agent selected from propylene glycol, 1:3 butylene glycol, sorbitol, and sodium hyalurate as a moisturizing agent; 0.8 to 1% by weight of a natural antioxidant as an anti-deterioration agent; 0.4 to 0.6% by weight of a preservative (sorbic acid); A shampoo composition containing as a main component an herbal medicine composed of 0.3 to 0.5% by weight of lavender fragrance and a method for producing the same,
그 제조방법으로는, 샴푸조성물에 피부질환 예방 및 치유기능을 부여하는 쌀 및 콩의 배아 25중량%, 초록색의 미성숙 떪은 감 25중량% 그리고 송구지, 마디풀, 산모, 화전초 및 속수 각각 10중량%로 이루어진 제1군의 한방 식물약재 조성물 100중량부를 20중량%의 에탄올 수용액 400중량부에 침지하여 온도 70~75℃로 유지시켜 열처리하여 총중량 200중량부가 될 때까지 열처리한 후 에탄올 수용액 출출액과 식물약재 잔사를 분리하고 식물약재 잔사를 물 200중량부에 침지하여 고압하에서 온도 140~150℃ 고온으로 유지시킨 상태에서 1시간 열처리하여 물추출액과 잔사를 분리하고 물추출액과 상기 에탄올 수용액을 혼합한 혼합추출액을 온도 80℃로 유지시킨 상태에서 증류하여 에탄올을 회수하고 감압농축하여 점도3~4포이즈의 제1군 한방식물약재의 혼합추출액을 얻는 1단계공정;In the manufacturing method, 25% by weight of rice and soybean embryos that impart skin disease prevention and healing functions to the shampoo composition, 25% by weight of green immature sweet persimmon, and 10% each 100 parts by weight of the herbal plant medicine composition of the first group consisting of% is immersed in 400 parts by weight of a 20% by weight aqueous ethanol solution, maintained at a temperature of 70 to 75°C, heat-treated until the total weight reaches 200 parts by weight, and then the ethanol aqueous solution extract And the plant medicine residues are separated, and the plant medicine residues are immersed in 200 parts by weight of water and heat-treated for 1 hour while maintaining the temperature at 140~150℃ under high pressure to separate the water extract and the residue, and the water extract and the ethanol aqueous solution are mixed. One-step process of distilling one mixed extract while maintaining the temperature at 80°C to recover ethanol and then concentrating under reduced pressure to obtain a mixed extract of group 1 herbal medicines having a viscosity of 3 to 4 poise;
샴푸조성물에 항균성 및 살균성을 부여하는 어성초 50중량%, 쇠비름 25중량%, 대황(장군풀) 25중량%로 이루어지는 제2군의 한방식물약재 100중량부를 20중량%의 에탄올 수용액 400중량부에 침지하여 온도 70~75℃로 유지시켜 열처리하되 총중량 200중량부가 될 때까지 열처리한 후 에탄올 추출액과 한방식물약재 잔사를 분리시킨 다음 온도 80℃를 유지시킨 상태에서 증류하여 에탄올을 회수하고 감압농출하여 점도 3~4포이즈의 제2군 한방식물약재의 에탄올 수용액의 추출액을 얻는 2단계공정;100 parts by weight of herbal medicines of the second group consisting of 50% by weight of Eoseongcho, 25% by weight of purslane, and 25% by weight of rhubarb (janggun grass), which impart antibacterial and sterilizing properties to the shampoo composition, are immersed in 400 parts by weight of a 20% ethanol aqueous solution. Heat treatment by maintaining the temperature at 70~75℃, but after heat treatment until the total weight reaches 200 parts by weight, the ethanol extract and the herbal medicine residue are separated, then distilled while maintaining the temperature at 80℃ to recover the ethanol, and concentrated under reduced pressure to obtain a viscosity of 3 A two-step process of obtaining an extract of an aqueous ethanol solution of the second group herbal medicines of ~4 poise;
샴푸 조성물에 탈모방어기능, 모발의 건강유지 및 발모기능을 부여하는 자소엽, 녹차, 하수오, 창포, 당광나무(큰잎광나무), 쐐기풀을 각각 동량으로 이루어진 제3군의 한방식물약재 100중량부를 30중량%의 에탄올 수용액 150중량부에 침지하여 온도 20~25℃로 유지시킨 상태에서 3~4개월간 발효시켜 알콜발효 추출액과 한방식물약재 잔사를 분리한 후 알콜발효 추출액을 80℃로 유지하고 증류하여 알콜을 회수하고 감압농축하여 점도 3~4포이즈의 제3군의 한방식물약재의 알콜발효추출액을 마련하는 3단계공정; 30 parts by weight of 100 parts by weight of herbal medicines of the 3rd group consisting of the same amount of perilla leaf, green tea, sorghum, iris, danggwang tree (large leaf gwangju), and nettle that give the shampoo composition the same amount of hair loss protection, hair health maintenance, and hair growth function. It is immersed in 150 parts by weight of an aqueous ethanol solution of 20% by weight and fermented for 3 to 4 months while maintaining the temperature at 20 to 25°C. After separating the alcohol fermentation extract and the herbal medicine residue, the alcohol fermentation extract is maintained at 80°C and distilled. A three-step process of recovering alcohol and concentrating under reduced pressure to prepare an alcohol fermentation extract of the third group herbal medicines having a viscosity of 3 to 4 poise;
아미노산 또는 폴리펩타이드에 지방산을 반응시켜서 된 약산성 음이온 계면활성제, 알킬암포디아세테이트, 알킬암포디푸로피오네이트, 아미다졸린의 양성이온 계면활성제 중에서 선택되는 하나의 계면활성제 30중량%의 수용액 56~67중량%에 제1군의 한방식물약재의 혼합추출액 12~16중량%, 제2군의 한방식물약재의 에탄올 추출액 9~12중량%, 제3군의 한방식물약재의 알콜발효추출액 6~8중량%, 샴푸조성물 분야에서 공지된 샴푸 조성물 재재의 담체들로서 피부 및 두피 영양성분으로 아스코르브산, 필수아미노산, 비타민 B1,B2,B6, 비타민C, 비타민D, 아세트산 중에서 선택되는 하나 이상의 영양성분 3~4중량%, 보습제 1.5~2중량%, 항산화제 0.8~1중량%, 소르브산 0.4~0.6중량%, 라벤드향 0.3~0.5중량% 첨가하여 온도 60~70℃를 유지시킨 상태에서 균질화시키는 4단계공정;으로 이루어진 한방식물약재를 이용한 삼푸조성물의 제조방법에 관한 것이다. An aqueous solution of 30% by weight of one surfactant selected from weakly acidic anionic surfactants, alkyl ampodiacetate, alkyl ampodifuropionate, and amidazoline amphoteric surfactants prepared by reacting fatty acids with amino acids or polypeptides 56 to 67 12-16% by weight of mixed extract of herbal medicines of group 1, 9-12% by weight of ethanol extract of herbal medicines of group 2, 6-8% by weight of alcoholic fermentation extract of herbal medicines of group 3 %, one or more nutritional ingredients selected from ascorbic acid, essential amino acids, vitamins B1, B2, B6, vitamin C, vitamin D, and acetic acid as skin and scalp nutrients as carriers for shampoo composition materials known in the field of shampoo compositions. 4 steps to homogenize while maintaining a temperature of 60 to 70°C by adding wt%, moisturizing agent 1.5 to 2 wt%, antioxidant 0.8 to 1 wt%, sorbic acid 0.4 to 0.6 wt%, and Labend flavor 0.3 to 0.5 wt% It relates to a method of manufacturing a sampu composition using a herbal medicine consisting of a process;
이와 같이, 본 발명의 샴푸조성물은 피부를 자극하지 않고 무해하며, 2차공해를 발생시키지 않는 친환경적이라 할 수 있고, 피부질환의 에방 및 치유기능이 잇어 피부 및 두피질환의 감염을 에방할 수 있으며, 각종 피부질환의 치유가 가능하며 황사와 같은 독성있는 미세먼지, 알레르기성 꽃가루, 풀독이 피부에 접촉되거나 벌에 쏘이거나 벌레에 물렸을 때 해독작용이 있고, 그 밖에도 지속적으로 사용시 탈모방지 및 발모효과를 기대할 수 있으며, 우수한 항균 및 살균작용과 변질방지기능이 부여된 한방식물약재를 이용한 샴푸조성물이라 할 수 있다.As described above, the shampoo composition of the present invention is harmless without irritating the skin, and can be said to be environmentally friendly without causing secondary pollution, and prevents infection of skin and scalp diseases due to the prevention and healing function of skin diseases. , It is possible to heal various skin diseases, and has detoxification when toxic fine dust such as yellow dust, allergic pollen, and grass poison come into contact with the skin, bee stung, or be bitten by insects. It can be expected, and it can be said that it is a shampoo composition using herbal medicines that have excellent antibacterial and sterilizing effects and anti-deterioration functions.
본 발명은 상술한 특정의 바람직한 실시 예에 한정되지 아니하며, 청구범위에서 청구하는 본 발명의 요지를 벗어남이 없이 당해 발명이 속하는 기술분야에서 통상의 지식을 가진 자라면 누구든지 다양한 변형 실시가 가능한 것은 물론이고, 그와 같은 변경은 청구범위 기재의 범위 내에 있게 된다.The present invention is not limited to the specific preferred embodiments described above, and any person having ordinary knowledge in the technical field to which the present invention pertains without departing from the gist of the present invention claimed in the claims can implement various modifications Of course, such changes are intended to be within the scope of the description of the claims.
본 발명의 명세서 전체에서, 어떤 부분이 다른 부분과 "연결"되어 있다고 할 때, 이는 "직접적으로 연결"되어 있는 경우 뿐만 아니라, 다른 부재를 사이에 두고 "간접적으로 연결"된 것도 포함한다. 또한, 어떤 부분이 어떤 구성요소를 "포함"한다고 할 때, 이는 특별히 반대되는 기재가 없는 한 다른 구성요소를 제외하는 것이 아니라 다른 구성요소를 더 포함할 수 있는 것을 의미한다.Throughout the specification of the present invention, when a part is "connected" with another part, this includes not only the case of being "directly connected" but also "indirectly connected" with another member therebetween. In addition, when a part "includes" a certain component, it means that other components may be further included rather than excluding other components unless specifically stated to the contrary.
본 발명에서 사용되는 용어들은 본 발명에서의 기능을 고려하여 정의된 용어들로서, 이는 사용자, 운용자의 의도 또는 관례에 따라 달라질 수 있으므로, 이러한 용어들에 대한 정의는 본 발명의 기술적 사항에 부합되는 의미와 개념으로 해석되어야 할 것이다.The terms used in the present invention are terms defined in consideration of functions in the present invention, and since these may vary according to the intention or custom of users or operators, the definitions of these terms correspond to the technical matters of the present invention. And should be interpreted as a concept.
그리고, 아래 실시 예에서의 선택적인 용어는 하나의 구성요소를 다른 구성요로부터 구별하기 위해 사용되는 것으로서, 구성요소가 상기 용어들에 의해 제한되는 것은 아니다. 이하, 본 발명을 설명함에 있어서, 본 발명의 요지를 불필요하게 흐릴 수 있는 관련된 공지기술에 대한 상세한 설명은 생략한다.In addition, optional terms in the following embodiments are used to distinguish one component from other components, and the component is not limited by the terms. Hereinafter, in describing the present invention, detailed descriptions of related known technologies that may unnecessarily obscure the subject matter of the present invention will be omitted.
본 발명은 환경친화적이고 인체에 해가 없으며 피부, 두피 및 모발에 자극을 줄이기 위해 가능한한 화학합성물질을 줄이고 천연의 한방식물약재로 대체하므로서 피부질환 예방 및 치유기능, 항균 및 살균기능을 갖는 한방식물약재를 이용한 샴푸조성물 및 그 제조방법에 관한 것으로, 이를 구체적으로 설명하면, The present invention is environmentally friendly, harmless to the human body, and reduces chemical synthesis as much as possible to reduce irritation to the skin, scalp and hair, and replaces it with natural herbal medicines, thereby preventing and curing skin diseases, and having antibacterial and sterilizing functions. It relates to a shampoo composition and a method of manufacturing the same using a plant medicine, and if described in detail,
본 발명의 샴푸조성물은, 아미노산 또는 폴리펩타이드에 지방산을 반응시켜서 된 약산성의 음이온 계면활성제 또는 베타인, 알킬암포디아세테이트, 알킬암포디푸로피오네이트, 아미다졸린의 양성이온 계면활성제 중에서 선택되는 하나 이상의 계면활성제 30중량%의 수용액 56~67중량%; 피부질환 예방 및 치유기능을 갖는 쌀 배아 및 콩의 배아 25중량%, 초록색을 띤 미성숙 떪은 감 25중량%, 그리고 송구지, 마디풀, 산모, 화전초 및 속수 각각 10중량%로 이루어진 제1군 한방 식물약재의 혼합추출액 12~16중량%; 항균성 및 살균성을 갖는 어성초 50중량%, 쇠비름 25중량%, 및 대황(장군풀) 25%로 이루어진 제2군의 한방식물약재의 에탄올 수용액 추출액 9~12중량%; 발모기능 및 탈모방지기능을 갖는 자소엽, 녹차잎, 당광나무, 어성초, 하수오, 창포 및 쐐기풀을 각각 동일량으로 하여 이루어진 제3군 한방식물약재의 알콜발효추출액 6~8중량%; 샴푸 기술분야에서 널리 공지된 샴푸조성물 재재의 담체들로서 피부, 두피 및 모발의 영양성분으로 아스코트브산, 필수아미노산, 비타민 B1,B2,B6, 비타민C, 비타민D, 아세트산 중에서 선택되는 하나 이상의 영양성분 3~4중량%; 프로피렌글리콜, 1:3부틸렌글리콜, 솔비톨, 히알루산나트륨 중에서 선택되는 하나 이상의 보습제 1.5~2중량%; 변질방지제로서 고시폴(gossypol), 시사몰(sesamol), 시트르산(citric acid), 아스코르브산을 동량으로 이루어진 천연 항산화제 0.8~1중량%; 보존재로서 소르브산 0.4~0.6중량%; 라벤드향 0.3~0.5중량%;로 조성된다.The shampoo composition of the present invention is one selected from a weakly acidic anionic surfactant or betaine, alkyl amphodiacetate, alkyl ampodifuropionate, amidazoline amphoteric surfactant prepared by reacting a fatty acid with an amino acid or a polypeptide. 56 to 67% by weight of an aqueous solution of 30% by weight of the above surfactant; Group 1 herbal medicine consisting of 25% by weight of rice germ and soybean germ, 25% by weight of greenish immature persimmon, and 10% by weight each of sorghum, edulis, maternal, hwajeoncho and soksu, each with skin disease prevention and healing function 12-16% by weight of mixed extract of plant medicinal materials; Eoseongcho 50% by weight having antibacterial and bactericidal properties, purslane 25% by weight, and 9 to 12% by weight of the ethanol aqueous solution extract of the herbal medicine of the second group consisting of 25% of rhubarb (janggun grass); 6-8% by weight of alcoholic fermentation extract of group 3 herbal medicines consisting of the same amount of perilla leaf, green tea leaf, danggwang tree, Eoseongcho, hawthorn, iris and nettle, each having a hair growth function and a hair loss prevention function; One or more nutritional ingredients selected from ascotbic acid, essential amino acids, vitamins B1, B2, B6, vitamin C, vitamin D, and acetic acid as nutrients for skin, scalp and hair as carriers for shampoo composition materials well known in the shampoo technology field. 3-4% by weight; 1.5 to 2% by weight of one or more moisturizing agents selected from propylene glycol, 1:3 butylene glycol, sorbitol, and sodium hyalurate; 0.8 to 1% by weight of a natural antioxidant consisting of the same amount of gossypol, sesamol, citric acid, and ascorbic acid as an anti-deterioration agent; 0.4 to 0.6% by weight of sorbic acid as a preservative; It is composed of 0.3 to 0.5% by weight of lavender flavor.
또한 본 발명 샴푸조성물의 제조방법은, 상기 제1군의 한방식물약재 조성물 100중량부를 20중량% 에탄올 수용액 400중량부에 침지하여 온도 70~75℃로 유지시켜 열처리하여 총중량 200중량부가 될 때까지 열처리한 후 에탄올 수용액 출출액과 한방식물약재 잔사를 분리하고 식물약재 잔사를 물 200중량부에 침지하여 고압으로 온도 140~150℃ 고온으로 유지시킨 상태에서 1시간 열처리하여 물추출액과 한방식물약재 잔사를 분리하고 물추출액과 상기 에탄올 수용액을 혼합한 혼합추출액을 온도 80℃로 유지시킨 상태에서 증류하여 에탄올을 회수하고 감압농축하여 점도3~4포이즈의 제1군 한방식물약재의 혼합추출액을 얻는 1단계공정;In addition, the method for preparing the shampoo composition of the present invention includes immersing 100 parts by weight of the herbal medicine composition of the first group in 400 parts by weight of a 20% ethanol aqueous solution and maintaining the temperature at 70 to 75°C until the total weight reaches 200 parts by weight. After heat treatment, the ethanol aqueous solution extract and the herbal medicine residue are separated, and the plant medicine residue is immersed in 200 parts by weight of water and heat-treated for 1 hour while maintaining a high temperature of 140~150℃ under high pressure. 1 to separate and distill the mixed extract obtained by mixing the water extract and the ethanol aqueous solution at a temperature of 80°C to recover ethanol and concentrate under reduced pressure to obtain a mixed extract of group 1 herbal medicines with a viscosity of 3 to 4 poise. Step process;
제2군 한방식물약재 100중량부를 20중량%의 에탄올 수용액 400중량부에 침지하여 온도 70~75℃로 유지시켜 열처리하여 총중량 200중량부가 될 때까지 열처리한 후 에탄올 수용액 추출액과 한방식물약재 잔사를 분리하고 애탄올 수용액을 온도 80℃로 유지시킨 상태에서 증류하여 에탄올을 회수하고 감압농출하여 점도 3~4포이즈의 제2군 한방식물약재의 에탄올 수용액 추출액을 얻는 2단계공정;After immersing 100 parts by weight of group 2 herbal medicines in 400 parts by weight of 20% by weight of ethanol aqueous solution, heat treatment by maintaining the temperature at 70-75°C and heat treatment until the total weight reaches 200 parts by weight, and then the ethanol aqueous solution extract and the herbal medicine residues are mixed. A two-step process of separating and distilling the aqueous ethanol solution at a temperature of 80° C. to recover ethanol and concentrate under reduced pressure to obtain an aqueous ethanol solution extract of the second group herbal medicines having a viscosity of 3 to 4 poise;
상기 제3군의 한방식물약재 100중량부를 30중량%의 에탄올 수용액 150중량부에 침지하여 온도 20~25℃로 유지시킨 상태에서 3~4개월간 발효시켜 알콜발효 추출액과 한방식물약재 잔사를 분리한 후 알콜발효추출액을 80℃ 유지시켜 증류하여 알콜을 회수하고 감압농축하여 점도 3~4포이즈의 제3군 한방식물약재의 알콜발효추출액을 얻는 3단계공정;100 parts by weight of the herbal medicines of the third group were immersed in 150 parts by weight of an aqueous ethanol solution of 30% by weight and fermented for 3 to 4 months while maintaining the temperature at 20 to 25°C to separate the alcohol fermentation extract and the herbal medicine residues. After maintaining the alcohol fermentation extract at 80 ℃ distillation to recover the alcohol and concentrated under reduced pressure to obtain an alcoholic fermentation extract of the third group herbal medicines having a viscosity of 3 to 4 poise;
청구항 제1항의 음이온 계면활성제 및 양성이온 계면활성제 중에서 선택되는 하나의 계면활성제 30중량&의 수용액 56~67중량%에 제1군 한방식물약재의 혼합 추출액 12~16중량%, 제2군의 한방식물약재의 에탄올 수용액 추출액 9~12중량%, 제3군의 한방식물약재의 알콜발효추출액 6~8중량%, 그리고 샴푸조성물 기술분야에서 공지된 샴푸조성물 재재의 담체들로서 피부 및 두피 영양성분으로 아스코르브산, 필수아미노산, 비타민 B1,B2,B6, 비타민C, 비타민D, 아세트산 중에서 선택되는 하나 이상의 영양성분 3~4중량%, 글리세린, 푸로피렌글리콜, 1:3부틸렌글리콜, 솔비톨, 히알루산나트륨 중에서 선택되는 하나 이상의 보습제 1.5~2중량%, 변질방지제로서 고시풀, 시사몰, 시트르산, 아스코르브산을 각각 동량으로 이루어진 천연 항산화제 0.8~1중량%, 보존제로서 소르브산 0.4~0.6중량%, 라벤드향 0.3~0.5중량% 첨가하여 온도 60~70℃로 유지시켜 균질화시키는 4단계고정;으로 이루어진다.12-16% by weight of mixed extract of herbal medicines of group 1 in 56-67% by weight of an aqueous solution of 30% by weight & of one surfactant selected from the anionic surfactants and amphoteric surfactants of claim 1, herbal medicine of group 2 Ascorb as a nutrient ingredient for skin and scalp as carriers for a shampoo composition material known in the art of shampoo composition technology, as well as 9-12% by weight of an ethanol aqueous solution extract of plant medicines, 6-8% by weight of an alcoholic fermentation extract of herbal medicines of the third group. Acids, essential amino acids, vitamins B1, B2, B6, vitamin C, vitamin D, 3 to 4% by weight of one or more nutrients selected from acetic acid, glycerin, furopyrene glycol, 1: 3 butylene glycol, sorbitol, sodium hyaluronate 1.5 to 2% by weight of one or more moisturizing agents selected from, 0.8 to 1% by weight of natural antioxidants each consisting of the same amount of gosipul, cisamol, citric acid, and ascorbic acid as an anti-deterioration agent, 0.4 to 0.6% by weight of sorbic acid as a preservative, d It consists of a four-step fixation; adding 0.3 to 0.5% by weight of the bend and maintaining the temperature at 60 to 70°C to homogenize.
본 발명 샴푸조성물에 사용되는 음이온 계면 활성제에 사용된 지방산으로는 올리브유, 코코넛유를 사용하며, 올리브유의 특징은 열매육에 50~70%, 씨에 20%의 기름이 있으며, 기름의 70~84%는 올레인, 4~12%는 리놀레인으로 구성되어 있어 올리브기름은 대부분이 올레인이므로 낮은 온도에서도 굳어지지 않고 변질도 되지 않아 샴푸용으로 적합하며 세포의 생성을 촉진시키고 보습효과가 뛰어나며 가려움증을 해소하고 여드름을 진정시키는 효과가 있다. 코코넛유는 각종 지방산 이외에 칼슘, 마그네슘, 철분 등이 함유되어 있고 피부를 건강하게 하고 항균성이 있으며 면역력을 향상시킨다.Olive oil and coconut oil are used as fatty acids used in the anionic surfactant used in the shampoo composition of the present invention, and the characteristics of olive oil are 50-70% of the fruit meat and 20% of the oil of the seeds, and 70-84 of the oil. % Consists of olein and 4~12% of linolein. Olive oil is mostly olein, so it does not harden or deteriorate even at low temperatures, so it is suitable for shampooing. It promotes cell generation, has excellent moisturizing effect, and itching. It is effective in relieving skin and soothing acne. In addition to various fatty acids, coconut oil contains calcium, magnesium, and iron, makes the skin healthy, has antibacterial properties, and improves immunity.
상기 본 발명에서 사용되는 제1군의 한방식물약재 조성물의 추출액은 피부, 두피에서 발생되는 각종질환의 에방과 치유기능이 있으며 해독기능을 구비한 추출액으로 추출액을 구성하는 한방식물약재의 특성과 기능을 알아보면 쌀눈에는 레시틴이 풍부하게 함유되어 있고 이 레시틴은 인지질이라 불리는 특수영양 성분으로 필수불포화지방산이라 불리는 비타민F와 비타민B의 일종인 콜린, 이노시톨이 결합된 복합물질로서 레시틴의 섭취량이 줄어들면 혈액속의 지방질이 혈액에 녹지 못하고 지방질이 혈관에 녹지 못하고 지방질이 혈관에 쌓이게 되며 이로 인해 심장병, 뇌졸증, 당뇨병합병증, 동맥경화가 올 수 있고 혈액순환의 장애로 피부가 거칠어 질 수 있다.The extract of the herbal composition of the first group used in the present invention has a function of preventing and healing various diseases arising from the skin and scalp, and the characteristics and functions of the herbal medicine constituting the extract with an extract having a detoxification function. As a result, rice eyes are rich in lecithin, and this lecithin is a special nutrient component called phospholipid. It is a complex compound of vitamin F called essential unsaturated fatty acid, choline, and inositol, a kind of vitamin B. When the intake of lecithin decreases, Fat in the blood does not dissolve in the blood, fat does not dissolve in the blood vessels, and fat accumulates in the blood vessels, which can lead to heart disease, stroke, diabetes complications, arteriosclerosis, and impaired blood circulation, resulting in rough skin.
콩에는 단백질이 36!45%, 기름이 17~22% 들어 있고 이 밖에 트리테르페놀이드 사포닌(소야사포닌 A, B, C), 질소화합물, 탄수화물, 당, 펙틴, 무기물과 비타민이 함유되어 있다. 단백질의 80~90%는 필수아미노산 즉 아르기닌, 메티오닌, 트레오닌, 로이찐, 이소로이찐, 발린 등으로 이루어졌다. 씨의 인지질 함량은 높은데 레시틴 1~3.5%, 케파린 등이 있다. 질소화합물로는 아메닌, 구아닌, 콜린, 트리코넬린, 아미노산인 히스티딘이 있다.Soybeans contain 36!45% of protein and 17~22% of oil, in addition to triterphenolide saponins (soya saponins A, B, C), nitrogen compounds, carbohydrates, sugars, pectins, minerals and vitamins. . 80-90% of the protein is composed of essential amino acids such as arginine, methionine, threonine, leucine, isoleucine, and valine. Seeds have a high content of phospholipids, including 1 to 3.5% lecithin and keparin. Nitrogen compounds include amenine, guanine, choline, triconeline, and the amino acid histidine.
탄수화물은 물에 용해되는 것들로 이루어져 있으며 그 가운데에서 3.3~13%는 사카로즈이며, 회분에는 미량의 K, Mg, Cu, Fe, Mn, Ni, Zn이 함유되어 있고흔적의 Co, 그리고 인산이 있다. 씨에는 비타민, A, B1, B2, D, E, K와 이소플라본 배당체인 다이아드진과 테니스틴, 로비닌 등이 함유되어 있고 씨에는 비타민C가 없으나 싹티운 콩(대두황권)에는 P-아스파라긴이 많고 크산틴, 히포크산틴이 많은 양의 비타민C가 있으며, 또한 1.5~2Cm 길이로 싹을 틔워 햇볕에 말린 것을 동의 치료에서 대두권이라 하여 청량성 강장약 독풀이 약으로 사용하여 왔다.Carbohydrates are composed of those soluble in water, of which 3.3 to 13% is saccharose, and ash contains traces of K, Mg, Cu, Fe, Mn, Ni, Zn, and traces of Co and phosphoric acid. have. Seeds contain vitamins, A, B1, B2, D, E, K, and isoflavone glycosides, such as diadazine, tennis tin, and robinin. Seeds do not contain vitamin C, but sprouted beans (soybean hwangwon) contain P-asparagine. It has a lot of xanthine and hypoxanthine, and has a large amount of vitamin C, and it has been used as a refreshing tonic, poisonous medicine, called soybean sphere in the treatment of Dongui, which sprouts 1.5~2cm long and dried in the sun.
또한 콩 배아에는 일반적인 영양성분으로 단백질, 지방, 달질, 섬유, 회분, 미타민 B1, B2, 비타민 E, 콜린, 비오틴이 있고 기능성분으로서는 이소플라본, 피틴산, 레시틴, 사포닌이 함유되어 있고, 간의 해독기능과 스트레스 해소 기능이 있다.In addition, soybean embryos contain protein, fat, sweetness, fiber, ash, mitamine B1, B2, vitamin E, choline, and biotin as general nutrients. Functional ingredients include isoflavone, phytic acid, lecithin, and saponin, and liver detoxification It has a function and a function to relieve stress.
감의 잎에는 아스코르브산이 다량으로 함유되어 있고 어린잎에는 최고 1,200mg%가 함유되어 있는데 잎이 자라면서 낮아져 큰 잎에는 300mg%가 함유된다. 또한 비타민 P, B1, B2, K가 있고 정유, 유기산, 카로틴, 로이코 델피니딘과 그 베당체, 켐페롤-글루코시드, 미리찌트린, 요드가 확인되었다. Persimmon leaves contain a large amount of ascorbic acid, and young leaves contain up to 1,200mg%. As the leaves grow, they lower and contain 300mg% in large leaves. In addition, vitamins P, B1, B2, and K were found, and essential oils, organic acids, carotene, leuko delpinidine and its saccharides, camperol-glucoside, myrizithrin, and iodine were identified.
열매에는 당분이 9~15% 함유되어 있는데 25%까지 들어 있으며 그 가운데 환원당은 약 10%이다. Fruits contain 9-15% of sugar, up to 25%, of which reducing sugar is about 10%.
마른 열매(곶감)에는 당분 약 62%(포도당 14%, 과당 85% 기타)이다. 그 주성분은 포도당, 과당이고 서당은 적고 만니트와 펙틴도 많은데 마른 감(건사, 백시)의 표면에 묻은 흰 가루는 만니트이며 또한 트리테르페노이드인, 올레아놀산, 우르솔산, 베틀린산, 아트로핀에 길항하는 아세틸콜린 양 물질이 들어 있다. Dried fruit (dried persimmon) contains about 62% sugar (14% glucose, 85% fructose, etc.). Its main components are glucose and fructose, and there is little sugar and mannite and pectin, but the white powder on the surface of dry persimmons (dry, white) is mannite, and also triterpenoids, oleanolic acid, ursolic acid, vetlinic acid, atropine. Contains acetylcholine-like substances that antagonize to.
감의 떫은 맛은 약 8%의 탄닌질이 있기 때문이고 단감도 어린 때에는 탄닌이 산화되므로 단맛이 남게 된다. 떫은 감은 익어도 떫은데 그것은 산화효소가 매우 원활히 작용하기 때문이다. 그리하여 떫은 감은 뜨거운 물에 담그거나 약한 알콜 증기를 쏘여 탄닌질을 펙틴과 결합시켜 물에 불용성의 물질로 만들면 밤색의 얼룩점이 있고 물에 용해되지 않는다. The astringent taste of persimmon is about 8% of tannins, and sweet persimmons are also oxidized when tannins are young, leaving a sweet taste. Astringent persimmons are astringent even if they are cooked because oxidative enzymes work very well. Thus, if the astringent persimmon is immersed in hot water or struck with a weak alcoholic vapor, tannins are combined with pectin to make a substance insoluble in water, which has brown spots and does not dissolve in water.
또한 열매에는 아스코르빈산 30~50mg%가 들어 있고 마른 열매에는 400~920mg%가 들어 있으며 그 밖에 비타민 K,B1, B2, 트립톤, 카탈라제, 폴리페놀 옥시다제, 아밀라제와 같은 효소가 들어 있다. In addition, fruit contains 30-50mg% of ascorbic acid, and dried fruit contains 400-920mg%, and other enzymes such as vitamins K, B1, B2, tryptone, catalase, polyphenol oxidase, and amylase are contained.
감에 함유된 탄닌 질은 칼로 카테긴이며 7-메틸유글론, 디오스피린, 이소디오스피린, 033-118%의 단백질, 약간의 펙틴물질, 116~161% 프로테인, 031~085%의 기름, 061~072% 동, 망간, 철, 칼리움, 칼슘 및 요드 등이 미량 함유되어 있다. The tannins contained in persimmon are calocategin, 7-methyleuglone, diosspirin, isodiospirin, 033-118% protein, some pectin substances, 116~161% protein, 031~085% oil, 061 It contains ~072% copper, manganese, iron, potassium, calcium and iodine in trace amounts.
감 탄닌을 이용하기 위해서는 감 탄닌이 많이 함유된 어린 떫은 감을 잘라서 말린 것을 사용하는 것이 유리하다. 감 탄닌은 뱀이나 벌레에 물리거나 쏘일 때 동상, 화상에 사용하며 감의 잎은 끓여 감잎차로 해서 장복하면 당뇨병, 고혈압, 변비, 위병이 치료되며 뾰두라지, 습진, 알레르기성 여드럼에도 좋은 치료효과가 있다.In order to use persimmon tannins, it is advantageous to cut and dry young astringent persimmons containing a lot of persimmon tannins. Persimmon tannin is used for frostbite and burns when being bitten or stung by snakes or insects, and persimmon leaves are boiled with persimmon leaf tea to cure diabetes, high blood pressure, constipation, and stomach ailments. have.
송구지는 잎에 200mg~1,000mg의 아스코르빈산이 함유되어 있고, 전초에는 크리파놀, 크리소파놀, 에모딘, 브라시딘산, 프란굴라에모딘, 안트라퀴논유도체 싱아산칼시움, 정유, 탄닌질이 있다. 뿌리에는 루마찐싱아산, 라나틴, 점액, 피스찌엔, 3!6%의 탄닌질, 4.2%의 옥시메틸안트라퀴논이 있으며 열매에 크리소파네인. 네포딘피스찌온, 네포시드가 들어 있고, 그 밖에도 살균작용이 있으며 민간에서는 여러가지 종양 특히 암치료에 사용하며 습진, 옴, 피부꽃돋이, 테선, 가려움증에 바른다. 각종 벌레에 물린데 효과가 있고 피부염에 사용한다. The leaves contain 200mg~1,000mg of ascorbic acid, and the outpost contains creepanol, chrysophanol, emordine, brassidic acid, frangulaemodine, anthraquinone derivative, sinnasancalcium, essential oil, and tannins. . The roots contain lumachinsinga acid, ranatin, mucus, pisciene, 3!6% tannins, 4.2% oxymethylanthraquinone, and chrysophanein in the fruit. It contains nepodinpission, neposide, and other sterilizing effects. In the private sector, it is used for the treatment of various tumors, especially cancer, and is applied to eczema, scabies, scabies, scabies, and itching. It is effective against various insect bites and is used for dermatitis.
마디풀은 일명 편축이라 하며 전초에 탄닌질 3%, 쿠에르쩨틴, 켐페롤, 미리찌트린, 델피니딘, 이소람레틴, 루테올린, 쿠에르찌트린, 히페로시드, 아비쿨라린, 적은량의 유리형 및 결합형 에모딘, 당분 2~3%, 아스코르빈산의 환원형 400~450mg%, 산화형 250~300mg%, 랍이 있다. Mardipul is called uniaxial, and in the outpost, tannins 3%, querzetin, camperol, myrizithrin, delphinidin, isoramretin, luteolin, querzitrin, hyperoside, abiculaline, and a small amount of free form and Conjugated Emodine, 2~3% sugar, 400~450mg% of reduced form of ascorbic acid, 250~300mg% of oxidized form, and lobster.
플라보노이드 배당체 가운데서 제일 많은 것은 아비쿨라딘이고 이를 물분해하면 쿠에르쩨틴과 아라비노즈 한 분자가 생긴다. Among the flavonoid glycosides, the most abundant is abiculadine, and when it is water-decomposed, one molecule of querzetin and arabinose is formed.
당으로는 람노즈, 크실로즈, 아라비노즈, 포도당, 갈락토즈 등이 확인되었으며 다당류는 회분 17~20%, 우론산 46~48%, 포도당 4~8%, 갈락토즈 23~36%, 아라비노즈 10~37%, 크실로즈 6~10%, 람노즈 22~33%로 이루어졌다. As sugars, rhamnose, xylose, arabinose, glucose, and galactose were identified. Polysaccharides were 17-20% ash, 46-48% uronic acid, 4-8% glucose, 23-36% galactose, and arabinose. It consisted of 10 to 37%, xylose 6 to 10%, and rhamnose 22 to 33%.
또한 전초에는 카페산, 클로로 겐산 싱아산, 탄닌질, 사포닌이 있으며 정유, 카로틴, 쿠마린인 스코폴레틴과 움벨라 페론, 점액, 살리찔산, 글루코탄닌, 페르시카리올, 휘발성 알칼로이드, 펙틴이 있고 뿌리에는 옥시메틸 안트라키논이 있다. In addition, there are caffeic acid, chlorogenic acid, tannins, and saponins in the outpost, and there are essential oils, carotene, and coumarins such as scopoletin and umbella peron, mucus, salicylic acid, glucotannin, persicariol, volatile alkaloids, pectin, and roots. Oxymethyl anthraquinone.
전초의 알콜 엑기스는 자궁수축약, 피멋이약에 쓰고 달임약은 콩팥염, 신석증, 폐결핵에 사용한다.The alcohol extract of the outpost is used for uterine contractions and pimuti medicine, and the decoction is used for kidney inflammation, nephrolithiasis, and pulmonary tuberculosis.
동의 치료에서는 오줌내기약, 방광염, 습성황달, 적리, 곽란 등에 사용한다.In the treatment of consent, it is used for peeing medicine, cystitis, wet jaundice, jeokri, and gwakran.
이풀은 세계적으로 널리 퍼져 있어 많은 나라에서 민간약으로 사용되고 있으며 수렴약, 피멎이약, 대장염, 위장염, 적리 땀내기약으로 학질, 감기, 오줌내기약으로 콩팥염과 신석증, 황달 폐결핵에 사용하고 그 밖에도 아픔멎이약, 방부약으로서 상처를 아물게 하는데 특히 화상, 잇몸염, 각종 벌레에 물린데에 효과가 있고 피부염, 옴에도 사용한다.Since it is widely spread around the world, it is used as a folk medicine in many countries. It is used as astringent medicine, blood stop medicine, colitis, gastroenteritis, as a medicine for sweating, cold, as medicine for peeing, kidney inflammation, nephrolithiasis, jaundice and pulmonary tuberculosis. As a pain-stopping medicine and antiseptic, it heals wounds. It is especially effective for burns, gingivitis, and various insect bites. It is also used for dermatitis and scabies.
산모(괴싱아)는 여러 해 살이 풀로서 뿌리와 줄기에 유리형 및 결합형의 크리소파놀, 에모딘, 옥시 메틸안트라키논인 루미찐, 크리소파네인, 크리소판산, 크리소파놀안트론, 탄닌질, 네포딘과 그 배당체 네포시드가 있다.Maternal (Göshinga) is a perennial herb, free and bound to the roots and stems of chrysophanol, emidine, and oxymethylanthraquinones such as luminicine, chrysophanein, chrysophanic acid, chrysophanolanthrone, There are tannins, nepodins and neposides, their glycosides.
전초에는 산성 싱아산칼리움 11%, 마른 잎에 아스코르빈산 750~1200mg이 들어 있다. 잎에는 카페산, 몰식자산, 프로토 카테킨산, 클로로겐산, p-크마르산, 페룰라산, 쿠에르쩨틴, 델피니딘, 찌아니딘, 루틴, 히페로시드, 철염, 루미찐이 들어 있다. Outpost contains 11% acidic potassium sinasan, and 750-1200 mg of ascorbic acid in dry leaves. The leaves contain caffeic acid, molesic acid, protocatechinic acid, chlorogenic acid, p-xmaric acid, ferulaic acid, querzetin, delpinidine, ziidine, rutin, hyperoside, iron salt, and lumitin.
뿌리 달임약은 설사, 적리, 장무력증, 위염에 먹으며 설사약, 오줌내기약, 땀내기약으로도 먹으며 전초는 신석류, 황달, 비타민 결핍증에 사용하고 피멋이약으로 장궁출혈, 열내림약으로 열병과 폐결핵약으로 쓰며 잎즙은 아픔멋이약으로 류마치스 및 허리 아픔에 사용하고 뱀이나 벌레, 동물에 물렸을 때 해독약으로 사용하고 피부병, 피부염증, 옴, 습진에도 효과가 있다.Root decoction is eaten for diarrhea, red blood, intestinal weakness, gastritis, and is also used for diarrhea, peeing, and sweating. The outpost is used for kidney pomegranate, jaundice, and vitamin deficiency. It is used as a drug for pulmonary tuberculosis, and leaf juice is used for rheumatism and lower back pain as a pain moth medicine. It is also used as a detoxifying agent when bitten by snakes, insects, and animals. It is also effective in skin diseases, skin inflammation, scabies, and eczema.
화건초는 여러 해 살이의 풀로서 꽃필 때 줄기를 말려서 사용하며 전초에는 사과산 칼시움과 세토헵 툴로즈 성분이 들어있고 이당은 발효되지 않으며 광합성 과정에 C4가 분해되어 탄산가스로 될 때 그 수용체로서 작용을 한다. Hwa-hay is a perennial herb, and the stems are dried and used when flowering. The outpost contains calcium malic acid and cetoheptulose components, and disaccharides are not fermented, and as a receptor when C4 is decomposed into carbon dioxide gas during photosynthesis. It works.
동의 치료에서는 열내림약, 독풀이약으로 종처, 상처, 피부염증, 어린이 단독, 뱀에 물린데 사용한다. In the treatment of consent, it is used as a fever-down medicine and poison repellent medicine for swelling, wounds, skin irritation, children alone, and snake bites.
민간요법에서는 곪은 상처에 붙이거나 뱀에 물린 데에 사용한다. In folk remedies, it is used to attach to festered wounds or to bite a snake.
속수는 천금자라고도 하며 씨를 속수자라 하고 속수자에는 기름 40~48%, 쿠마린 성분인 다프네틴과 에스쿨레린 0.6%, 비쿠마린 성분으로서 파두의 센 설사성분과 비슷한 물질인 에우폴, α-에우포르볼, 이소에우포롤, 에우포르베틴, 이소에우포르베틴 등 트리테르페노이드 성분이 있다. Soksu is also known as Cheongeumja, and the seeds are called Soksuja, and 40~48% of oil, daphnetin and esculerin 0.6% as coumarin components, and Eupol, α-Eupor, a substance similar to the strong diarrhea of Fadu as a coumarin ingredient. There are triterpenoid components such as cheeks, isoeupolol, euphorbetin, and isoeuporbetin.
이 식물의 수지에서 얻은 조제에우포르본이란 물질은 트리테르펜알콜의 혼합물이다. 이 밖에 기름에는 에우포르비오-스테로이드, 7-히드록시라티롤, 라티롤 디아세타트니코티나트와 에폭시라티폴, 인게놀-3-헥사데카로이드 성분이 있다. The crude euphorbone obtained from the resin of this plant is a mixture of triterpene alcohols. Other oils include euphorbio-steroid, 7-hydroxylatyrol, latyrol diacetatnicotinat, epoxylatifol, and ingenol-3-hexadecaloid.
식물체의 젖액 속에는 씨와 같은 테르펜 화합물이 있으며 L-도파 17%, 에우포르바인이 있고 잎에는 켐페롤-3-글루쿠로니드, 타락세롤, 타락세튼 성분이 있다.In the milk of the plant, there are terpene compounds such as seeds, L-dopa 17%, euphorbine, and leaves contain camperol-3-glucuronide, taraxerol, and taraxetone.
동의 치료에서는 씨를 통경약으로 폐경, 센 오줌내기 염증약으로 물고임과 토하면서 먹지 못할 때 쓰고 또한 뱀에 물렸을 때 먹는다.In the treatment of copper, seeds are used when menopause and strong urine are used as an inflammatory drug to urinate and vomit and cannot eat, and are eaten when a snake is bitten.
속수씨 가루 또는 줄기와 입즙은 사마귀, 죽은 깨에 장기간 바르면 없어진다.Soksu seed powder or stem and mouth juice disappear after a long period of application to warts and dead sesame seeds.
쇠비름은 한 해 살이 풀이며 쇠비름의 뿌리를 비비면 붉은색을 띠는데 이는 효소의 작용에 의하여 물감이 생기기 때문이다. Purslane is a year-old grass, and when the roots of purslane are rubbed, they have a reddish color, because paints are created by the action of enzymes.
쇠비름은 전초에 ℓ-노르아드레날린 025%와 거의 같은 양의 도파민 그리고 적은량의 도파가 있다. 노르아드레날린의 활성은 합성품과 같다. 또한 카리움염(질산염, 염산염, 류산염의 형태로 있는데 K2O로 계산하여 생것에 1%, 마른 것에 10~17%) 많은 량의 유기산(사과산, 레몬산, 싱아산), 아미노산,(글루타민산, 아스파라긴산, 알라닌), 강심배당체, 안트라키논배당체, 알카로이드 반응이 있다. Purslane has almost the same amount of dopamine as 025% of ℓ-noradrenaline and a small amount of dopa in the outpost. The activity of noradrenaline is the same as that of synthetic products. In addition, carium salts (nitrate, hydrochloride, and leucate are in the form of K2O, calculated as K2O, 1% for raw, 10 to 17% for dry), large amounts of organic acids (saperic acid, lemon acid, singic acid), amino acids, (glutamic acid, aspartic acid). , Alanine), cardiac glycosides, anthraquinone glycosides, and alkaloid reactions.
신선한 전초에는 수분함량 94~96%이고 건조시킨 전초에는 %가 수분함량 45~66%이며, 건조시킨 전초에는 조단백 14~24%, 조지방 37%~58%, 조희분 25~27%, 단당류 2~3%, 당 44~6%, 물분해되기 쉬운 다당류 9~14%, 농마 02~25%, 비타민 B1,과 C, 카로틴 94~17mg%, 니코틴산 25~50mg%, 토코페롤 2~6mg%, 미량원소인 아연, 동, 망간, 닉켈, 철 등으로 구성되며 그 밖에 사포닌, 탄닌질이 들어 있다. Fresh outpost has 94-96% moisture, and dried outpost has a water content of 45-66%, and dried outpost has 14-24% crude protein, 37%-58% crude fat, 25-27% crude sugar, and 2 monosaccharides. ~3%, sugar 44~6%, polysaccharides susceptible to water decomposition 9~14%, farm horse 02~25%, vitamin B1, fruit C, carotene 94~17mg%, nicotinic acid 25~50mg%, tocopherol 2~6mg%, It is composed of trace elements such as zinc, copper, manganese, nickel, and iron, and contains saponins and tannins.
전초의 알콜 추출액은 대장균, 적리균, 티푸스균에 대한 억균작용이 있으며 임상실험결과 자료에 의하면 트리코모나스증과 세균성 이질에 치료효과가 뚜렷하게 나타낸다.The alcohol extract of outpost has an antibacterial effect on Escherichia coli, red lychee, and typhus. According to the data from clinical trials, it clearly shows the therapeutic effect on trichomoniasis and bacterial dysentery.
동의 치료에서는 이질, 종창, 단독, 옴, 습진, 벌레독과 뱀독 등에 배농성 독풀이약, 오줌내기약으로 사용한다.In the treatment of sinus, it is used as a draining poison medicine for dysentery, swelling, single, scabies, eczema, insect poison and snake venom, etc.
대황(장군풀) 뿌리에는 안트라키논 유도체 3.2~6.6%, 탄닌질 8.2~13.6%가 들어 있고 주로 레인, 알로에에모딘, 에모딘, 크로소파놀 피스찌온 등의 배당체로 되어 있고 크리소파놀안트론, 센노시드 A,B,C가 들어 있다.The roots of rhubarb (janggungrass) contain 3.2-6.6% of anthraquinone derivatives and 8.2-13.6% of tannins, and are mainly composed of glycosides such as lane, aloe modin, emidine, and crosophanol pistion, and chrysophanolanthrone and sennoside. Contains A, B, and C.
탄닐질은 몰식자산과 몰식자산의 배당체(글루코갈린), 대황탄닌산, 카페산으로 되어 있으며 잎에는 루틴과 유기산 아스코르빈산이 있고 많은 양의 칼리움 염이 있다. 장군풀뿌리의 작용으로는 적리균, 티푸스균, 대장균에 대한 항균작용이 있다.Tanyl is composed of molybdenum and glycosides (glucogallin), rhubarb tannic acid, and caffeic acid. The leaves contain rutin and organic acids ascorbic acid, and a large amount of potassium salts. The action of the general grass roots has an antibacterial action against red pepper, typhus, and Escherichia coli.
상술한 바와 같이 제2군의 한방식물약재들 중 어성초의 잎에는 크에르찌트린이 함유되어 있고 이 성분은 대장균, 디프스균, 파라디프스균, 적리균, 임균, 포도상균 사상균에 항균작용이 있고 테카노일 아세트알데히드 성분은 비병원상 곰팽이는 물론 백선균 무좀균에 대한 항균작용과 포도상균, 임균, 항산성세균에도 항균작용이 있으며 쇠비름 및 대황 역시 대장균, 디프스균, 적리균에 대한 항균작용이 있어 제2군의 한방식물약자로부터 얻은 추출액을 함유하고 있는 본 발명 샴푸조성물에 우수한 항균성이 부여되어 전염성의 병원균의 감염을 방지할 수 있다.As described above, among the herbal medicines of the 2nd group, the leaves of Eoseongcho contain querzitrin, and this ingredient has antibacterial activity against Escherichia coli, dips bacteria, paradips bacteria, erysipelas, gonococcus, staphylococcus aureus filamentous bacteria. Canoyl acetaldehyde component has antibacterial action against non-pathogenic fungus, as well as thymus fungus, and against Staphylococcus aureus, gonococcus, and acidic bacteria, and purslane and rhubarb also have antibacterial action against Escherichia coli, diffs, and red lychee. Excellent antimicrobial properties are imparted to the shampoo composition of the present invention containing the extract obtained from group 2 herbal medicines, so that infection of infectious pathogens can be prevented.
본 발명의 제3군의 한방식물약재의 성분과 그 기능을 알아보면 자소엽은 들깨와 비슷하지만 줄기와 잎의 보라색을 띠고 있고 전초에는 정유 0.5%를 함유하고 있으며 정유의 주성분은 자소엽의 향기성분인 ℓ-페릴라알테히드와 ℓ-리모넨 이고 적큰양의 α-피넨, 디트로구민, 알데히드가 있으며 잎의 가지색소는 찌아닌클로이드와 그의 파라구마르산 에스테르이며 그밖에 아데닌, 아르기닌이 있다.When looking at the ingredients and functions of the herbal medicines of the third group of the present invention, perilla leaf is similar to perilla, but the stem and leaves are purple, and the outpost contains 0.5% of essential oil, and the main component of the essential oil is the fragrance of perilla leaf. Constituents are ℓ-perillaaldehyde and ℓ-limonene, and there are large amounts of α-pinene, ditrogumin, and aldehyde, and the eggplant pigments of the leaves are thianin clod and its paragumaric acid ester, and in addition, adenine and arginine are included. .
씨에는 기름, 비타민 B1 약300mg% 있으며 기름의 주성분은 리놀라산, 리놀레인산이며 약간의 스테아린산 팔미틴산의 글리세리드이고 비누화되지 않는 스테린이 들어있다.The seeds contain about 300mg% of oil and vitamin B1, and the main components of the oil are linolaic acid and linoleic acid, and some of the glycerides of palmitic acid, stearic acid, and stearin, which are not saponified.
작용으로는 페릴라 알데히드의 안티옥심은 사탕보다 200~2,000배의 단맛이 있고 방부작용이 있으며 물에 녹지 않으며 열처리하면 분해되어 독성이 있어 먹지 못한다.In terms of action, antioxime of perilla aldehyde has 200 to 2,000 times sweeter taste than candy, has preservative action, does not dissolve in water, is decomposed when heat treated and is toxic, so it cannot be eaten.
녹차나무는 사철푸른 떨기나무이고 잎은 두껍고 타원형이다. The green tea tree is a green bush, and its leaves are thick and oval.
차잎 가공방법에 따라 크게 녹차, 홍차, 꽃차(화차)로 나눈다. Depending on the tea leaf processing method, it is largely divided into green tea, black tea, and flower tea (hwacha).
녹차는 잎을 따서 증기로 찌거나 뜨거운 바람으로 산화효소를 비활성화시킨 다음 말린다.Green tea leaves are picked, steamed with steam, or dried with hot air to deactivate oxidative enzymes.
성분으로 잎에는 코페인, 크산틴, 테오필린이 있고 차나무탄닌은 9~15%로 그 가운데 가용성탄닌은 약3%, 불용성탄닌은 9.9%이다.As ingredients, leaves contain copain, xanthine, and theophylline, and tea tree tannin is 9-15%, of which soluble tannin is about 3% and insoluble tannin is 9.9%.
차나무탄닌은 테아카테골의 몰식자산 에스테르 즉 3-갈로일-ℓ-에피-갈로테콜이고 또한 스테로이드인테아스테롤α-스피나스-테롤과 트리테르페노이드인β-γ-헥세놀 50~60%, α-β헤세놀 5%, 이소부틸알데히드, 이소발레릴알데히그, 메틸에틸 이세토알데히드, 길초산, 살리찔산메틸, 벤질알콜, 리날롤 등이다. 알칼로이드는 코페인 이외에도 테오필린, 테오브로민이 있고 크산틴, 아데닌, 히포크산틴, 파라크산틴, 메틸크산틴, 인사틴이 있다. 또한 레찌틴, 누클레오티드아데닌, 누클레오티드찌토신, 철과 망간이 들어있는 누클레오프로테이드와 쿠마린, 비타민- B1,B2,B3,B5,K 가 있다.Chanamu tannin is an ester of the acategol's molar property, that is, 3-galloyl-l-epi-galotechol, and the steroid inteasterol α-spinas-terol and the triterpenoid β-γ-hexenol 50-60% , α-β hesenol 5%, isobutylaldehyde, isovalerylaldehyde, methylethyl isetoaldehyde, gilacetic acid, methyl salicylate, benzyl alcohol, linalol, and the like. In addition to copain, alkaloids include theophylline, theobromine, and xanthine, adenine, hypoxanthine, paraxanthine, methylxanthine, and insatin. There are also recitin, nucleotide adenine, nucleotide chitosine, nucleotides and coumarins containing iron and manganese, and vitamins-B1, B2, B3, B5, K.
녹차의 코페인은 숨쉬기가 약한때, 심장활동이 약한때, 급성진염성질벽, 알콜과 아편 중독시 독풀이약으로 사용한다.Green tea's copain is used as a poison remedy when breathing is weak, heart activity is weak, acute pain, and alcohol and opium poisoning.
당광나무는 사철푸른나무로 잎은 두텁고 타원형 또는 달걀모양이고 남방식물이므로 요즘 약초로 온실에서 재배하고 있다. 성분으로는 열매에 올레아놀산, α-만니톨이 들어있고 씨에는 14.9%의 기름, 만니톨이 있고, 지방산은 고체산 19.5%(팔매틴산과 스테아르산), 불포화지방산 80.5%(올레인산과 리놀산)이다.Danggwang tree is a four-year-old green tree with thick leaves, oval or egg-shaped, and it is a southern herb, so it is cultivated in greenhouses as a herb these days. Ingredients include oleanolic acid and α-mannitol in fruit, 14.9% of oil and mannitol in seeds, and 19.5% of solid acids (palmatic acid and stearic acid) and 80.5% of unsaturated fatty acids (oleic acid and linoleic acid).
동의치료에서 강장약으로 몽이 허하고 속에 열감이 있는 질병, 허리아픔, 귀울림, 가스두근거림, 불면증, 변비에 사용하며, 늙지않게 하는 보약으로 장기간 복용하면 몸을 거뜬하게 하고 희머리를 검게하며 눈을 밝게하며 결핵에도 사용한다.As a tonic medicine in motion therapy, it is used for drowsiness and heat sensation, back pain, tinnitus, gas palpitations, insomnia and constipation. Brightens and is also used for tuberculosis.
하수오는 뿌리에 옥시메틸 안트라키논 유도체(크리소파놀, 크리소파놀안트론, 에모딘, 에모딘모노메칠에테르, 피스찌온과 그 배당체, 레인) 1.8%, 농마 약 45%, 기름 약 3%, 레찌틴 3.7%, 물에 용해되는 물질 약 26%, 라폰틴, 2,3,5,4'-테트라히드록시스틸벤-2-글리코시드가 들어있다.Sewage roots contain oxymethyl anthraquinone derivatives (Chrysophanol, Chrysophanolanthrone, Emodine, Emodine Monomethyl Ether, Pistion and its glycosides, Lane) 1.8%, Farm Horse 45%, Oil 3%, Ree. It contains 3.7% of chitin, about 26% of a substance soluble in water, lapontin, 2,3,5,4'-tetrahydroxystilben-2-glycoside.
동의치료에서 뿌리를 노인성 변비, 옴, 습진, 피부병에 사용, 강정약, 장수약으로 오래전부터 이용되어 왔다. 강장, 보혈작용은 지황뿌리나 천문동보다 훨씬 쎈것으로 알려져 있다.In the treatment of copper, the roots have been used for senile constipation, scabies, eczema, skin diseases, and as a medicine for longevity and longevity. It is known that the tonic and blood-blood effects are much stronger than those of Rehmannia Root or Cheonmun-dong.
구기자나무의 열매(구기자)에는 비타민 0.1%, 카로티노이드인 제아크산틴이 있고 열매껍질에서 피살리엔이 분리되었으며 최근 구기자나무열매에서 처음으로 생물학적물질인 스코폴레틴을 분리하였으며 또한 카로노이드와 스테린도 분리하였다. 잎에는 배타인, 다우코스테린, 아스코르브산이 있다. The fruit of Goji berry (Goji berry) contains 0.1% vitamin and zeaxanthin, a carotenoid, and fisaliene was isolated from the bark. Recently, scopoletin, a biological material, was first isolated from Goji berry. Separated. The leaves contain exclusives, doucosterine, and ascorbic acid.
구기자(열매)와 뿌리껍질은 모두 보약으로 사용하고 뿌리껍질은 염증약, 폐결핵, 당뇨에 효과가 있으며 Both goji (fruit) and root bark are used as a rejuvenating medicine, and the root bark is effective against inflammatory drugs, pulmonary tuberculosis, and diabetes.
동의치료에서는 구기자는 허리아픔, 무력증, 어지럼증, 머리아픔에 쓰며 오래 장복하면 뼈를 든든하게 하고 몸을 가볍게 하며 흰머리를 검게하고 눈을 밝게 한다고 한다.In the treatment of motion, goji is said to be used for back pain, asthenia, dizziness, and head pain. Long prolonged periods of time strengthen bones, lighten the body, darken gray hair, and brighten eyes.
쐐기풀의 쐐기털에는 개미산, 초산, 버터산으로 이루어진 자극성인 산물질이 있으며 잎에는 비타민K, 배당체인 우르티찐, 탄닌질, 개미산, 아스코르브산, 비타민B2, 판토텐산, 프로토프르피린, 코포로포르피린, 시토스테린, 히스타민, 레찌딘이 들어 있으며 그밖에 카로티노이드인 β-카로틴, 크산토필, 크산로필에폭시드, 비올라크산틴이 있다.The nettle hair of nettle contains irritating acid substances consisting of formic acid, acetic acid, and butyric acid, and the leaves contain vitamin K, glycosides urticin, tannins, formic acid, ascorbic acid, vitamin B2, pantothenic acid, protoprphyrin, koporoporphyrin, cytotoxic acid. It contains sterin, histamine, and rezidine, and other carotenoids, such as β-carotene, xanthophyll, xanthophyllepoxide, and violaxanthin.
잎의 우림약은 피의 응고성을 높히며 헤모글로빈의 함량과 적혈구수를 늘이며 또한 자군평활근의 긴장도를 높히고 수축을 세게하며 혈관수축작용이 있으며 이러한 작용성분은 비타민K와 클로로필이라 할 수 있다. Rainforest medicine of leaves increases blood coagulation, increases the content of hemoglobin and red blood cell count, and also increases the tension of the autogenous smooth muscle, tightens the contraction, and has vasoconstriction. These active ingredients are vitamin K and chlorophyll.
잎의 달인 물로 머리를 감으면 머리칼이 빠지지 않는다.If you wash your hair with water, the decoction of leaves, your hair will not fall out.
이상의 제3군의 한방시기물약재들은 발모 및 탈모방지 기능을 갖는 한방식물약재들로 이들의 조성물 알코발효추출액이 함유된 샴푸조성물로된 샴푸를 지인들을 통해 6개월간 사용하게 한후 결과를 확인해본 결과 가는 머리카락이 점점 줄어들어 최종에 가서는 사람마다 차이는 있으나 최초 세면기에 빠지는 머리카락의 양의 1/3~1/4로 감소함을 확인할 수 있고, 암으로 탈모된 남자(63세의 4) 원 상태로 완전 복귀되었음을 확인할 수 있었고, 가마를 중심으로 가운데 머리가 빠지면서 머리카락의 밀도가 희박하여 두피가 보일정도의 58세 및 71세의 여인은 밀도가 조밀해지면서 정상적인 밀도의 절반으로 회복된 것으로 보였으며 대머리형 남자로서 솜털과 아주 가는 머리카락이 남아있는 대머리형은 솜털과 아주 가는 머리카락이 굵어지면서 자라나 두피를 은폐하고 있으나 머리카락이 아주 가늘고 자라는 길이가 4cm 자라면 더자라지 않고 밀도가 희박한 편이다.그밖에 대머리의 남자 2명은 육모의 효과가 나타나지 않고 탈모 정지효과는 있는 것으로 확인하였다. 나머지 지인들도 거의 동일한 결과를 확인하므로서 본 발명 샴푸로부터 발모(육모)효과와 탈모방지 효과가 있는 것으로 확인되었다.The above group 3 herbal medicines are herbal medicines that have the function of preventing hair growth and hair loss, and the results were confirmed after having used shampoos made of shampoo compositions containing alcohol fermentation extracts for 6 months with acquaintances. As thin hair gradually decreases, it varies from person to person at the end, but it can be confirmed that it decreases to 1/3 to 1/4 of the amount of hair that falls into the first wash basin, and a man who has hair loss due to cancer (4 in 63 years old) is in its original state. It was confirmed that the females aged 58 and 71, whose hair density was thin and the scalp was visible due to the thin hair falling out of the center of the kiln, appeared to have recovered to half of the normal density as the density became dense. As a bald-headed man, the bald-headed type, with downy and very thin hair remaining, grows thicker and hides the scalp, but if the hair is very thin and grows up to 4cm in length, it does not grow any further and the density is thin. It was confirmed that the two men in the group did not show the effect of hair growth and had the effect of stopping hair loss. As the rest of the acquaintances confirmed almost the same results, it was confirmed that the shampoo of the present invention has a hair growth (hair growth) effect and a hair loss prevention effect.
상술한 바와 같이 본 발명 샴푸조성물은 지속적으로 사용할 경우 각종 피부질환의 예방 및 치유효과가 있고 항균 및 살균효과가 있어 전염성의 병원균에 의한 감염을 예방할 수 있어 위생적이라 할 수 있고, 탈모방지 및 발모효과를 기대할 수 있는 다기능성의 한방약재식물을 이용한 샴푸조성물과 그 제조방법이라 할 수 있다. As described above, when the shampoo composition of the present invention is used continuously, it can prevent and cure various skin diseases, and has antibacterial and sterilizing effects, so it can prevent infection by infectious pathogens, so it can be said to be hygienic. It can be said that it is a shampoo composition and its manufacturing method using multifunctional herbal medicinal plants that can be expected.
본 발명의 범위는 상세한 설명보다는 후술하는 특허청구범위에 의하여 나타내어지며, 특허청구범위의 의미 및 범위 그리고 등가 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본 발명의 범위에 포함되는 것으로 해석되어야 한다.The scope of the present invention is indicated by the claims to be described later rather than the detailed description, and all changes or modified forms derived from the meaning and scope of the claims and equivalent concepts should be interpreted as being included in the scope of the present invention.
Claims (7)
쌀배아 및 콩배아 25중량%, 초록색의 미성숙 떫은감 25중량%, 송구지, 마디풀, 산모, 화건초 및 속수 각각 10중량%로 이루어진 한방식물약재의 혼합추출액 12~16중량%;
어성초 50중량%, 쇠비름 25중량%, 및 대황 25중량%로 이루어진 한방식물약재의 에탄올 수용액 추출액 9~12중량%;
자소엽, 녹차잎, 당광나무열매, 어성초, 하수오, 창포 및 쐐기풀을 각각 동량으로 하여 이루어진 한방식물약재의 알콜 발효 추출액 6~8중량%;
샴푸 조성물 기술분야에서 널리 알려진 샴푸 재재의 담체들로서 아스코트브산, 필수아미노산, 비타민 B1,B2,B6, 비타민C, 비타민D, 아세트산 중에서 선택되는 하나 이상의 영양성분 3~4중량%;
푸로피렌글리콜, 1,3부틸렌글리콜, 솔비톨, 히알루산나트륨 중에서 선택되는 하나 이상의 보습제 1.5~2중량%;
변질방지제로서 고시폴(gossypol), 시사몰(sesamol), 시트르산, 아스코르브산을 각각 동량으로 이루어진 천연 항산화제 0.8~1중량%;
보존제인 소르브산 0.4~0.6중량%;
라벤드향 0.3~0.5중량%;로 조성된 한방식물약재를 이용한 샴푸 조성물.30 weight of a weakly acidic surfactant in the pH range of 4.5 to PH 5.5, and at least one surfactant selected from an alkyl amphodiacetate, an alkyl ampodifuropionate, and an amidazoline amphoteric surfactant made by reacting a fatty acid with an amino acid or a polypeptide % Of an aqueous solution of 56 to 67% by mass;
12-16% by weight of mixed extract of herbal medicine consisting of 25% by weight of rice germ and soybean germ, 25% by weight of green immature astringent persimmon, 10% by weight of pine, stalk, maternal, hwa hay and soksu;
Eoseongcho 50% by weight, purslane 25% by weight, and 9 to 12% by weight of the ethanol aqueous solution extract of the herbal medicine consisting of 25% by weight of rhubarb;
6-8% by weight of an alcoholic fermented extract of herbal medicine consisting of perilla leaf, green tea leaf, danggwang tree fruit, Eoseongcho, hawthorn, iris and nettle in equal amounts, respectively;
3-4% by weight of one or more nutrients selected from ascotbic acid, essential amino acids, vitamins B1, B2, B6, vitamin C, vitamin D, and acetic acid as carriers for shampoo materials well known in the art of shampoo composition;
1.5 to 2% by weight of one or more moisturizing agents selected from furopyrene glycol, 1,3 butylene glycol, sorbitol, and sodium hyalurate;
0.8 to 1% by weight of a natural antioxidant consisting of the same amount, respectively, of gossypol, sesamol, citric acid, and ascorbic acid as an anti-deterioration agent;
0.4 to 0.6% by weight of sorbic acid as a preservative;
Labend fragrance 0.3 ~ 0.5% by weight; shampoo composition using the herbal medicine composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190010500A KR102227533B1 (en) | 2019-01-28 | 2019-01-28 | Shampoo compound using oriental medicine and its manufacturing methods |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190010500A KR102227533B1 (en) | 2019-01-28 | 2019-01-28 | Shampoo compound using oriental medicine and its manufacturing methods |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20200093260A KR20200093260A (en) | 2020-08-05 |
KR102227533B1 true KR102227533B1 (en) | 2021-03-11 |
Family
ID=72041691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190010500A Active KR102227533B1 (en) | 2019-01-28 | 2019-01-28 | Shampoo compound using oriental medicine and its manufacturing methods |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102227533B1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102356799B1 (en) * | 2021-10-25 | 2022-02-08 | 김혜선 | Cosmetic composition for preventing hair loss comprising extracts derived from natural products |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100382602B1 (en) | 1999-09-03 | 2003-05-01 | 송시훈 | Compositions preventing lose of hair and promoting growth of hair |
KR101050613B1 (en) | 2008-11-24 | 2011-07-19 | (주)웰바이코리아 | Cosmetic composition containing plant extract having antioxidant effect and anti-wrinkle and moisturizing effect |
KR20160069953A (en) * | 2014-12-09 | 2016-06-17 | (주)산엔들 | Herbal shampoo composition for promoting hair growth |
KR20170110455A (en) * | 2016-03-23 | 2017-10-11 | 고범순 | Manufacturing method of shampoo composition for improving state of scalp and hair and shampoo composition manufactured thereby |
KR101848671B1 (en) * | 2016-09-20 | 2018-04-16 | 주식회사 얼라셀바이오 | Functional composition for improving hair loss and hair growth comprising plant cell fermentation extract and functional cosmetic comprising the same |
KR20180064185A (en) * | 2016-12-05 | 2018-06-14 | 유한회사 아이에스티케이3 | Process for producing fermented rice bran lactic acid bacteria fermentation liquid and The cosmetic composition containing the same |
-
2019
- 2019-01-28 KR KR1020190010500A patent/KR102227533B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
KR20200093260A (en) | 2020-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DeFilipps et al. | The medicinal plants of Myanmar | |
KR101478945B1 (en) | Shampoo composition containing native plant extracts and natural oriental material extracts | |
Kumar et al. | Recent trends in potential traditional Indian herbs Emblica officinalis and its medicinal importance | |
Jain et al. | Traditional Indian herb Emblica officinalis and its medicinal importance | |
Panda | Handbook on medicinal herbs with uses: medicinal plant farming, most profitable medicinal plants in India, medicinal plants farming in India, plants used in herbalism, medicinal herbs you can grow, medicinal herbs and their uses, medicinal herbs, herbal & medicinal plants, growing medicinal herb, most profitable medicinal herbs growing with small investment, herbal medicine herbs | |
KR101146206B1 (en) | Cosmetic Composition And Composition of Skin External Application | |
Kumar et al. | Recent trends in medicinal uses and health benefits of Indian traditional herbs Aegle marmelos | |
Besong et al. | Medicinal and economic value of Dialium guineense | |
KR102288724B1 (en) | Multi functional shampoo for pet comprising functional complex composition for improving function of anti-bacterial, sterilization, anti-inflammation and skin soothing, and enhancing skin immune and manufacturing method thereof | |
KR101128564B1 (en) | The manufacturing process of lithospermum erythrorhizon soap controlled by vineger | |
Hutchens | A Handbook of Native American Herbs: The Pocket Guide to 125 Medicinal Plants and Their Uses | |
KR100867514B1 (en) | Manufacturing method of paper soap | |
Fahamiya et al. | Review on cucumis melo: ethnobotany and Unani medicine | |
KR102039718B1 (en) | Feminine cleanser and manufacturing method thereof | |
KR101941753B1 (en) | a functional antiseptic composite for wet wipes | |
Robinson | The New Family Herbal | |
KR100989944B1 (en) | A mixed herb medicine extracts having antioxidant whitening activity | |
KR102227533B1 (en) | Shampoo compound using oriental medicine and its manufacturing methods | |
KR100633380B1 (en) | Herbal cosmetic composition for atopic skin containing specific herbal extract mixture | |
KR20160147424A (en) | An enzyme composition for treating metabolic disorders including extracts wasong | |
KR101835799B1 (en) | A cosmetic composition for manufacturing by the using of propolis, and the cosmetic manufactured by the composition | |
KR101723962B1 (en) | Atopic dermatitis mitigate functional composition using environmentally friendly natural ingredients | |
KR101742819B1 (en) | Medicinal herb extract for growing or restoring hair and cosmetic composition comprising the same | |
Sewwandi et al. | Literature review on selected Ayurvedic formula in the management of wound healing | |
KR100656531B1 (en) | Herbal composition for preventing hair loss and promoting hair growth |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20190128 |
|
PA0201 | Request for examination | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20200225 Patent event code: PE09021S01D |
|
AMND | Amendment | ||
PG1501 | Laying open of application | ||
E601 | Decision to refuse application | ||
PE0601 | Decision on rejection of patent |
Patent event date: 20210114 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20200225 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
X091 | Application refused [patent] | ||
AMND | Amendment | ||
PX0901 | Re-examination |
Patent event code: PX09011S01I Patent event date: 20210114 Comment text: Decision to Refuse Application Patent event code: PX09012R01I Patent event date: 20200722 Comment text: Amendment to Specification, etc. |
|
PX0701 | Decision of registration after re-examination |
Patent event date: 20210303 Comment text: Decision to Grant Registration Patent event code: PX07013S01D Patent event date: 20210208 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I Patent event date: 20210114 Comment text: Decision to Refuse Application Patent event code: PX07011S01I Patent event date: 20200722 Comment text: Amendment to Specification, etc. Patent event code: PX07012R01I |
|
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20210308 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20210308 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20240402 Start annual number: 4 End annual number: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20250226 Start annual number: 5 End annual number: 5 |